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Leucocyte-independent glomerular injury. N. W. Boyce and S. R.
Holdsworth. Department of Medicine, Prince Henry's Hospital,
Melbourne, Australia. Glomerular fixation of anti-glomerular basement
membrane antibody (anti-GBM-Ab) is associated with complement (C)
activation, neutrophil accumulation, and renal injury. The relative
contributions to injury by each of these potential mediators is unclear,
and cannot be adequately dissected by in vivo studies based on
mediator depletion. An isolated perfused kidney system (IPK) was
therefore used to assess the capacity of anti-GBM-Ab binding in the
absence of all circulating inflammatory mediators, and of antibody
induced C activation to produce glomerular injury in this circulating-cell
free system. Control perfusions (with Krebs-Henseleit buffered 5%
albumin solution containing normal sheep globulin) showed stable
function (at 60 mm protein excretion 0.155 0.028 mg/mm; GFR 0.63
0.06 mllminlg; vascular resistance 2.82 0.20 mm Hg/mllmin). At 60
mm anti-GBM-Ab alone, binding at a kidney fixing antibody level
(KFA) 385 tg/g, induced a significant (P < 0.01) increase in mean
protein excretion (1.214 0.380 mg/mm) and hemodynamic deteriora-
tion (GFR 0.34 0.04 mllminlg; resistance 4.20 0.56 mm Hg/mllsec).
At a lower dose (KFA 183 g/g) anti-GBM-Ab alone had no effect on
protein excretion. However C activation by a non-injurious dose of
anti-GBM-Ab induced significant proteinuria (1.871 0.533 mg/mm)
together with an augmented hemodynamic response (vascular resist-
ance 8.51 1.66 mm Hg/ml/min). Glomerular permselectivity was
further assessed by fractional clearances of neutral dextran and dextran
sulphate. The increased protein excretion induced by anti-GBM-Ab
binding was associated with loss of the glomerular filter's negative
charge barrier. These IPK studies demonstrate that anti-GBM-Ab
binding can itself produce renal injury, including loss of the glomerular
capillary negative charge barrier with proteinuria, in the absence of all
circulating inflammatory mediator systems. They also indicate that C
activation is capable of direct glomerular injury, independent of the
recruitment of circulating inflammatory cells.
Glomerular procoagulant activity (PCA) in experimental anti-glomer-
ular basement membrane antibody-induced glomerulonephritis (anti-
GBM GN). P. G. Tipping and S. R. Holdsworth. Department of
Medicine, Monash University, Prince Henry's Hospital, Melbourne,
Australia. The mechanisms of glomerular fibrin deposition (GFD) in
GN are unknown. Evidence suggests that the intrinsic coagulation
pathway is not involved. Macrophages, which are prominent in cres-
centic GN, can activate the extrinsic coagulation pathway by expres-
sion of PCA, and may potentially initiate GFD. Previous studies
comparing two experimental models of anti-GBM GN showed that,
despite similar glomerular injury (extent of cellular proliferation and
proteinuria), significant GFD only accompanied glomerular macro-
phage infiltration. Macrophage depletion (with nitrogen mustard treat-
ment) blocked GFD (Holdsworth and Tipping, ISN Abstract, 1984).
The current studies aimed at detecting and characterizing tissue
thromboplastins in normal and nephritic glomeruli. Lysates of isolated
glomeruli (l0 per ml) were prepared by freeze-thawing, from three
groups of animals: (1) rabbits with passively induced autologous phase
anti-GBM GN (PAGBMGN); (2) nitrogen mustard-treated (macro-
phage-depleted) rabbits with PAGBMGN; (3) control rabbits given
normal rabbit serum. The PCA in the lysates was assayed in a standard
one stage clotting test in vitro, and its activity was compared to
standard rabbit thromboplastin (Sigma). The PCA dose response curves
were found to be parallel to the curve for standard rabbit
thromboplastin. Significantly augmented PCA was present in lysates
from rabbits with PAGBMGN (425 100 mU/103 gloms) compared to
nitrogen mustard-treated rabbits (39 15 mU/103 gloms) and control
rabbits (30 11 mU/103 gloms) P < 0.005. Glomerular PCA was
dependent on the presence of factors VII and V, but not on factors XII
and VIII, indicating activation of the extrinsic coagulation pathway. Its
activity was inhibited by concanavalin A, a known inhibitor of
macrophage PCA. Thus macrophage-dependent GFD in PAGBMGN
was associated with augmented levels of PCA in glomerular lysates.
This PCA had similar characteristics to macrophage PCA, suggesting
that macrophages within these glomeruli may directly initiate GFD in
this model, by expression of PCA.
IgA and IgG production by lymphocytes in IgA glomerulonephritis. S.
I. Per!, A. Wilkinson, and D. G. Williams. Department of Renal
Medicine, Guy's Hospital, London, England. IgA glomerulonephritis is
characterized by glomerular deposits of IgA and IgG and raised serum
IgA. Immunoglobulin (Ig) production by lymphocytes and its control in
this disease were examined as follows. Ig production by peripheral
blood mononuclear cells (PBC) in culture was measured, using an
ELISA method, in 29 patients and 36 normal controls. Spontaneous
production of IgA and IgG was significantly increased in the patients
(IgA: patients, mean 629.2 SEM 138.4; controls, mean 206.9 SEM 27.83
ng/ml: P < 0.001; IgG: patients, mean 379.9 SEM 67.9; controls, mean
216,2 SEM 22.3 ng/ml; P < 0.01. 1gM production was not significantly
different. In cultures stimulated by pokeweed mitogen (PWM) there
was increased production of all three Igs compared to spontaneous
production, but no significant differences between the patients and
controls. To assess the role of plastic adherent cells (macrophages) in
the increased Ig production, cultures of whole PBC and PBC depleted
of adherent cells (AC) were performed in nine patients and 12 controls
using PWM as mitogen.
IgA, nglml
+AC mean (5EM) —AC mean (sEM) P
Patients (9)
Controls (12)
2213.4 (707.9)
742.8 (202.1)
962.8 (275.9)
909.6 (210.3)
< 0.04
NS
IgG, ng/ml
+AC mean (5EM) —AC mean (5EM) P
Patients (9)
Controls (12)
3352.7 (745.7)
1872.4 (375.6)
1575.8 (710.1)
1755.1 (399.8)
< 0.038
NS
1gM production was not affected by removal of adherent cells and this
effect of adherent cells was not found in other forms of nephritis. IgA1
and IgA2 subclasses in PBC culture supernatants were measured
(ELISA) and IgA2 was found to be significantly greater in the patients.
Conclusions: (I) Patients with IgA nephropathy have increased spon-
taneous IgA and IgG production by PBC; (2) this increased production
is influenced by helper monocytes; (3) the abnormal IgA subclass
distribution suggests the origin of the IgA is from gut-associated
lymphatic cells (GALT).
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Established fibrin-related experimental glomerulonephritis (ON): Com-
parison of treatment with streptokinase (SK) and ancrod. P. G. Tipping,
N. M. Thomson, and S. R. Holdsworth. Departments of Medicine and
Nephrology, Monash University, Prince Henty's Hospital, Melbourne,
Australia. Fibrin is an important mediator of injury in the most
aggressive forms of human and experimental ON. Treatment with
conventional anticoagulants, however, has afforded no clear benefit in
human ON. Defibrination with ancrod is effective in experimental ON,
but its clinical benefit is not established. The use of SK has not been
assessed in experimental ON. In this study, the comparative effects of
treatment of established ON with SK and ancrod were assessed in
pre-immunized rabbits developing nephrotoxic serum nephritis. Five
groups, each of nine rabbits, were compared. Untreated rabbits devel-
oped renal failure (serum creatinine 625 120 gm/liter; normal 65 3
mIliter), in association with severe crescentic nephritis after 5 days.
Glomerular fibrin deposition (scored 0 to 3, according to its extent on
immunofluorescence, and assessed blindly on at least 25 glomeruli per
animal), was well established prior to treatment (fibrin score 0.9 0.1,
day 1) and reached 2.0 0.1 on day 5, Two groups of rabbits with
established ON (creatinines 204 35 m/1iter, and 207 74 tm/1iter on
day 1) were treated over the last 4 days of this model. Both forms of
treatment resulted in significant protection from loss of renal function
by day 5. (SK creatinine 258 68 m/1iter, P <0.025,ancrod creatinine
201 27 sm/liter, P < 0.025). Olomerular fibrin deposition was also
significantly reduced (SK fibrin score 0.6 0.1, P <0.01, ancrod fibrin
score 1.0 0.1, P < 0.01), although SK reduced fibrin deposition to a
greater extent than ancrod. Two further groups were treated over the
last two days of this model, when disease was more advanced.
Although glomerular fibrin deposition was reduced in both these
groups, no protection from loss of renal function was observed. It was
concluded that both SK and Ancrod treatment was effective in preserv-
ing renal function in established fibrin-related ON, if used early, but did
not affect the outcome of more established disease. Both agents
prevented further glomerular fibrin deposition, however only SK re-
duced glomerular fibrin to less than pre-treatment levels.
Renal venous hypertension: "The Nutcracker Syndrome". J. W.
MacD. Agar, D. B. Robertson, and D. L. Murphy. Departments of
Nephrology, Radiology and Urology, Geelong Hospital, Geelong,
Victoria, Australia. Intermittent macroscopic hematuria with interval
microscopic hematuria of non-glomerular origin, frequently precip-
itated or aggravated by exercise and accompanied by loin pain is a
perplexing problem encountered by the nephrologist or urologist.
Diagnostic tests for arterial hypertension, renal calculous disease, renal
arterial anomalies, glomerular disease (particularly IgA nephropathy)
and uroepithelial or renal tumors may be normal. The urological
literature recently reported "Renal Venous Hypertension" (RVH) and
the "Nutcracker Syndrome" (NS) as a cause of this syndrome, where
bleeding from the left ureter is shown by immediate post-exercise
panendoscopy. In NS, the left renal vein (LRV) is compressed between
the aorta and the superior mesenteric artery leading to distal RVH.
Renal venous variocosities leading to characteristic indentations on
pyelography or varicoceles in males may be seen. Special investigation
after panendoscopy includes intravenous pyeiography, renal angiogra-
phy with augmentation venography, differential venous pressures from
RRV, LRV, and IVC measured supine and erect with and without
vaisalva and high resolution CT scanning. Three cases of NS are
described with surgical lowering of the LRV out of "the nutcracker"
being performed in two, resulting in the resolution of both pain and
hematuria. Pressure studies have confirmed marked distal RVH on the
left, exacerbated by both valsalva and the erect position. Subsequent
further bleeding in one patient resulted in eventual left nephrectomy,
the histological studies of the nephrectomy specimen confirming defin-
able epithelialized venous communications between the renal venous
system and the renal pelvis. Attention is drawn to NS, which is a
pathological entity involving obstruction to the left renal venous drain-
age and which may be surgically correctable. This syndrome further
diminishes the diagnosis of "essential hematuria" and should be
considered when the usual diagnostic tests for hematuria fall to reveal
a diagnosis.
Enoxacin in the treatment of urinary tract infection. J. Bell, R.
Wyndham, and R. Bradbury. Repatriation General Hospital, Concord,
New South Wales, Australia. Enoxacin is a new, orally active antimi-
crobial of the quinoloneazaquinolone class. In this open trial, we
assessed its efficacy in the treatment of urinary tract infection (UTI),
treating 23 adults (age 23 to 72 years) with bacteriologically confirmed
UT!. Nine patients were thought to have pyelonephritis, (six recurrent,
three acute), fourteen cystitis (seven recurrent, seven acute). Twelve
patients had definite urinary tract abnormality and fourteen had signif-
icant nonrenal medical illness. Fourteen infections were due to E. coli,
two each of S. aureus and P. aeruginosa, one each to S. fecalis, C.
freundii, K. pneumoniae, S. marcescens, and P. stuartii. Patients were
treated 12th hourly for 7 days: eleven received 400 mg/day and 12
received 800 mg/day. All had sterile urine at the end of therapy. One
week after ceasing treatment, 12/14 patients with cystitis and all nine
with pyelonephritis were cured. One month after treatment, 11 of 19
evaluable patients were free of infection. There were two treatment
failures (infection with the same organism) at one week after cessation
of therapy. Four further patients relapsed with the same organism at
one month. Five of these six patients had urinary tract abnormality and
one had poorly controlled diabetes mellitus. One patient with pseudo-
monas UT! relapsed and had a second 10-day course of enoxacin: cure
was effected and the urine remained sterile at 6 weeks. Three patients
with normal renal function reported a total of four side effects (two
nausea, one headache, one dizziness): one patient with renal impair-
ment (p. creatinine 0.35 mmole/liter) developed dizziness, anorexia,
nausea, and pruritus, but elected to complete the course. There
appeared to be no adverse effects on renal or hepatic function during
treatment. Enoxacin is a well-tolerated, new antibiotic. Oral therapy for
one week eradicated the majority of infections in this group of hospital-
based patients.
Urinary 6-ketoprostaglandin F1, (6 KF1,) and thromboxane B2 (Tx B2)
excretion in obstructive uropathy in childhood. D. A. McCredie, R.
Qvist, and H. R. Powell. Department of Pediatrics, University of
Melbourne and Department of Nephrology, Royal Children's Hospital,
Melbourne, Australia. Urinary 6 KF1,. and Tx B2 excretion was studied
in 21 children with urinary tract obstruction before and after surgery to
relieve the obstruction. Early morning urine was collected on the day of
operation and, where possible, for three to four days post-operatively.
17 control patients, admitted for non-urological operations, and 26
normal children at home were also studied. Normal children consisted
of equal numbers of males and females and no significant sex difference
in prostanoid excretion was present. Results are summarized in the
table. No significant difference in 6 KF1,. excretion was found between
the three groups. However Tx B2 excretion was significantly higher in
both of the surgical groups with some very high levels being found in the
patients with obstruction. As these patients tended also to have higher
6 KFI,. excretion there was no significant difference in the ratio of 6
KFI. to Tx B2 between the two operative groups. Moreover, in more
than half of the obstructed patients, urinary Tx B2 excretion was within
the normal range, so that this measurement did not provide a good
indication of obstruction in most patients.
Normal Surgical Obstructed
controls controls patients
range range range
(median) (median) (median)
Urinary 6KF1,. 85 to 830 100 to 500 180 to 820
(mo1e/mole (350) (250) (410)
creatinine)
Urinary Tx 23 to 300 110 to 610 90 to 4330
B2(moie/mo1e (86) (130) (365)
creatinine)
6 KFl 1.19 to 36 0.41 to 8.2 0.09 to 4.7
Tx B2 (3.6) (1.4) (1.52)
Following operation excretion of both 6 KF1,. and Tx B2 increased to
approximately double the initial value by the following day, and then
declined over the next few days to the pre-operative level. A slight but
significant rise (approximately 30%) in both 6 KFI,,, and Tx B2 excretion
was also found in the control-operated patients.
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Intra-arterial verapamil prevents warm ischemia.induced acute renal
failure in dogs. D. R. Eisinger, M. G. Suranyi, P. Bracs, A. Farnsworth,
and A. G. R. Sheil. University of Sydney and Royal Prince Alfred
Hospital, Sydney, Australia. Recent evidence implicates a calcium-
mediated mechanism in warm ischemia-induced acute renal failure
(WI-ARF) post transplantation. This study evaluates the effects of
verapamil, a calcium antagonist, in the prevention of WI-ARF following
renal autotransplantation in the dog. Twenty-one mongrel dogs were
randomly allocated to three groups. Group I, control (eight dogs)
received 20 ml normal saline before a standardized 60-mm warm
ischemic insult to the left kidney. Group 2 (six dogs) received verapamil
(0.3 mg/kg) by i.v. injection and Group 3 (seven dogs) received
verapamil (0.3 mg/kg) by injection into the left renal artery prior to the
same ischemia. The left kidney was heterotopically grafted to the right
iliac fossa in the warm ischemia period. Contralateral nephrectomy was
performed. The dogs were followed to 7 days of serial serum creatinine
(Cr) estimations. Six of eight controls showed marked renal impairment
(Cr> 800 smoles/liter or death in renal failure). Three of six dogs given
iv. verapamil showed marked renal impairment. None of the dogs
receiving intra-arterial verapamil showed marked renal impairment (P
= 0.013, x2 test). Multivariate analysis indicated a significant reduction
in the rate of Cr rise in the intra-arterial group (P = 0.03). There was a
significant association (Spearman rank correlation P = 0.005) between
the Cr levels and the severity of histological damage, It is concluded
that intra-arterial administration of verapamil prior to a warm ischemia
insult significantly reduced both the incidence of marked renal failure
and the rate of post-ischemia Cr rise.
Immunopathology of fine-needle aspirate of renal allografts. A. Bishop,
B. M. Hall, J. Waugh, D. J. Tiller, G. G. Duggin, J. S. Horvath, and C.
Fraser. Department of Renal Medicine, Royal Prince Alfred Hospital,
Camperdown, Australia. The diagnosis of rejection in renal transplants,
particularly in the post-transplant oliguric phases or in patients treated
with cyclosporine, can be imprecise. Cytological analysis of fine-needle
aspiration biopsy specimens (FNAB) of transplant kidneys can be used
to establish whether there is immune inflammation in the kidney,
consistent with rejection. We have examined whether im-
munopathological techniques such as identification of T cell subsets
with immunofluorescent stains on a cytofluorograph or immunoper-
oxidase stains on cytospin preparations would assist or simplify the
diagnosis of rejection. One hundred-thirteen parallel FNAB and finger
prick samples from 33 patients were examined using immunofluores-
cence to count the number of T cells, T helper, T cytotoxic cells using
the monoclonal antibodies Tl 1, T4, and T8, respectively. Analysis of
differences in the T4:Tl 1, T8:T1 1, or T4:T8 ratios between blood and
FNAB failed to reveal a consistent trend associated with rejection
episodes. The red blood cell count in the FNAB was used on an index
of contaminations of blood and a corrected graft infiltrate of Tl 1, T4,
and T8 cells was derived and compared to the proportion of these cells
in blood. There was no consistent trend in cellular infiltrate in FNAB
from patients with rejection, compared to those with no rejection. From
these studies we concluded that the background contamination of blood
and non-specific infiltrate of lymphoid cells makes analysis of major
lymphoid cells difficult. Thus, we examined FNAB for changes which
are peculiar to rejection. Cytospin preparations from 52 FNAB from 29
patients were stained for HLA-DR and Tll. HLA-DR expression on
tubular cells occurred much more frequently and in greater intensity in
the samples from rejecting tissue than in samples from non-rejecting
tissue (P < 0.0005). Mononuclear cells expressing HLA-DR which
include activated T cells, B cells, monocytes, and macrophages, were
more frequent in samples from grafts with rejection (P < 0.001).
Activated T cells, identified on the basis of size and staining with Tl 1,
were also markedly increased in rejecting samples (P = 0.0005). Taking
all three features and scoring them on a semiquantitative scale, the
presence or absence of rejection was correctly predicted in 49 of 52
samples. We conclude that although counting of T cell subsets has little
predictive value in diagnosing rejection, concentration on the identifi-
cation of changes characteristic of rejection can lead to an accurate
diagnostic technique.
Immunopathology of renal allograft rejection analyzed with monoclo-
nal antibodies to mononuclear cell markers. G. A. Bishop, B. M. Hall, G.
G. Duggin, J. S. Horvath, A. G. R. Sheil, andD. J. Tiller. Department
of Renal Medicine, Royal Prince Alfred Hospital, Camperdown, Aus-
tralia. The composition of the mononuclear cell infiltrate in rejecting
renal allografts was determined on 96 renal biopsy and 22 nephrectomy
specimens by the use of monoclonal antibodies to mononuclear cell
surface markers and an indirect immunoperoxidase-staining technique.
Monoclonal antibodies were used to identify T cells (Tl 1), B cells (B 1),
helper/inducer T cells (T4), cytotoxic T cells (T8), activated T cells
(Tb), monocytes (OKM1), and HLA-DR antigens (1L2). During rejec-
tion, the composition of the infiltrate was heterogeneous, with T cells
and monocytes the most frequent subpopulations, and the intensity of
the inifitrate of the cells increased with the severity of rejection. B cells
and activated T cells, identified by OKT1O, were always in the minority
and did not increase with the severity of rejection. The T cell infiltrate
usually included large numbers of cells with the phenotypes of both the
helper/inducer (T4) and cytotoxic (T8) subclasses of T cells, which
suggests both delayed type hypersensitivity as well as direct cytotoxic
effector mechanisms contribute to rejection and increase with the
severity of rejection. Whether T4 or T8 predominated in the graft did
not relate to the ratio of T4:T8 in blood, although in the majority of
grafts there appeared to be a greater influx of T8 than T4 cells from
blood to graft. The pattern of infiltrate in cellular rejection in patients
immunosuppressed with cyclosporine was not different to that in
patients treated with a combination of azathioprine, prednisone, and
antilymphocyte globulin. T4 cells were more often the predominant
cells in rejection episodes occurring within weeks of transplant and in
those which were reversed with corticosteroid treatment. Rejection
episodes that did not respond to treatment with corticosteroids were
characterized by a predominance of T8 over T4 cells and T cells
infiltrating the glomeruli. In grafts with evidence of cellular rejection,
renal tubular cells were shown to have a marked increase in their
expression of class II HLA antigens compared to normal kidneys or
grafts with minimal rejection. The expression of HLA.DR antigens on
tubular graft cells would thus make them vulnerable to rejection
mediated by T4 cells whose activity is restricted to recognizing cells
bearing class H antigens. There was no relationship between incompat-
ibilities for class I and class II antigens and the presence of a T8 and T4
cellular infiltrate. Immunopathological studies have demonstrated the
cellular infiltrate associated with rejection of renal allografts is heter-
ogeneous. The presence of a predominance of T8 cells over T4 and a T
cell infiltrate in glomeruli suggests rejection that is likely to be resistant
to corticosteroid therapy and may indicate a need for use of other more
specific rejection therapy.
Sulindac: Is it really renal sparing? C. P. Swainson, P. Grfjiths, and
M. Watson. Christchurch Clinical School, Christchurch, New Zealand,
and University of Edinburgh, Edinburgh, United Kingdom. Sulindac is
an anti-inflammatory drug that does not affect renal PGE2 synthesis in
short-term studies. Eight subjects with chronic renal disease (GFR < 40
mI/mm) were given sulindac 200 mg (four individuals) or 600 mg
(remaining four) daily. GFR and ERPF were estimated by radioisotopes
(31Cr-EDTA and '311-PAH), sodium excretion by 24-hr urine collection
and PRA, and aldosterone and urinary PGE2 by radioimmunoassays.
Measurements were made before and after 28 days of treatment. ERPF
fell by a mean of 11%, but GFR was stable. PRA and aldosterone rose
(20 and 15%) and urinary PGE2 fell by 64% compared to baseline
values. One subject had nausea and disturbed liver function tests which
resolved after withdrawal of the drug and did not recur after the drug
was started again. Sulindac caused a small change in ERPF only and a
marked diminution of renal PGE2 excretion in this longer term study.
Calculation of effective renal plasma flow using 'I-orthoiodohippu-
rate: Comparison of four methods. D. J. Taylor, P. Griffiths, C. P.
Swainson, R. R. Bailey, and J. G. Turner. Departments of Nuclear
Medicine and Nephrology, Christchurch Hospital, Christchurch, New
Zealand. Estimation of the effective renal plasma flow (ERPF) using a
single i.v. injection of '251-orthoiodohippurate ('251.OIH) is a well-
validated alternative to the traditional para-aminohippuric acid clear-
ance. Following iv. injection, '251-OIH generates a multiexponential
plasma disappearance curve. By assuming a theoretical two-compart-
ment open mamillary model, the curve can be analyzed into two
exponential functions. Double exponential analysis of plasma disap-
pearance curves for calculation of ERPF requires multiple plasma
samples to define the curve, and sufficient length of time to adequately
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define the terminal slope of the curves. Several attempts have been
made to simplify both the collection of plasma samples and computing
methods by calculating approximations for estimated ERPF from only
one or two plasma samples. This study compared ERPF estimations
using three published approximation methods with a more precise
biexponential analysis. Fifty-three ERPF determinations were made on
21 patients with a wide range of renal function. Serial samples for 6 hr
after injection of '251-OIH were used to plot the plasma disappearance
curve, and a standard ERPF was calculated using biexponential analy-
sis of the curve. ERPF values calculated by three approximation
methods using limited plasma samples were compared to the standard
values. The % error of the estimated ERPF using three approximation
methods is shown in the table:
Method No.
Mean %
errora SD Range, %
Waal Manning & Bolli
(1980) 50 +70.0 51.3 +2.9 to + 189.9
Blaufox & Merrill
(1966) 53 +59.7 47.7 —5.5 to +312.1
Tauxe et al (1982) 51 + 18.3 20.4 —12.3 to +90.0
a + indicates overestimation; indicates underestimation.
With two of the three approximation methods, the overestimation
was particularly prominent in patients with moderate or severe renal
insufficiency (ERPF < 300 mI/mm). While the approximation methods
offer savings in time and comfort, their inaccuracy and unreliability
make them unsuitable for determining ERPF in renal insufficiency, For
research purposes, the more accurate biexponential analysis method is
recommended.
Serum 25 Hydroxyvitamin D (25 OHD) concentration in chronic renal
failure (CRF). T. J. Furlong, M. A. B. Thomas, L. S. Ibels, R. S.
Mason, A. Trube, and S. Posen. Departments of Endocrinology and
Renal Medicine, Royal North Shore Hospital, St. Leonards, New
South Wales, Australia. In view of conflicting results of 25 OHD levels
in patients with CRF, 25 OHD concentrations were measured in 149
patients, 73 with stable non-nephrotic CRF (Mean SDM, serum
creatinine 0.39 0.25 mmoles/liter), 57 on maintenance hemodialysis
(MHD), and 19 on continuous ambulatory peritoneal dialysis (CAPD).
No patient was receiving Vitamin D.
No. 25 OHD (nmoles/liter)
Normal controls 58 70 29.6
CRF 73 66 24.9 (NS)
MHD 57 93 51.3 (P < 0.01)
CAPD 19 44 22.8 (P < 0.001)
In non-dialysed CRF patients, 25 OHD correlated positively with
serum albumin (T = 0.39, P < 0.002), but not with urine protein/crc-
atinine ratios (r =
—0.24, N = 66) or with the inverse of serum
creatinine (r =
—0.15, N = 72). There was a negative correlation
between serum albumin and urine protein/creatinine ratios (r =
—0.44,
P < 0.001, N = 57), consistent with the known protein-binding of 25
OHD. 25 OHD presumably has an increased half-life in patients
receiving hemodialysis and is lost into the PD effluent in those on
CAPD. If low levels are found in patients with stable CRF, then causes
other than CRF should be considered.
The New Zealand Glomerulonephritis Survey: introductory report. L.
C. Williams, S. F. Hannan, and J. Y. Taylor, for the nephrologists and
renal pathologists of New Zealand. Department of Medicine, Auckland
Hospital, Auckland, New Zealand. A prospective study of primary
glomerulonephritis (GN) in adults was begun in 1973 to examine the
natural history of GN in a population whose diet and lifestyle differs
from that in the Old World, to provide a baseline and experience for
studies of treatments of GN, to study GN in the large Maori and Pacific
Islander (Polynesian) population, who are greatly overepresented in
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dialysis programs, and to compare the outcomes of different forms of
GN in a single country. New Zealand's isolation and good internal
communications gave access to all the 3¼ million population via the five
renal biopsy centers. Since then all biopsy-proven ON in those over 14
years of age has been recorded. Criteria for renal biopsy included
proteinuria of more than one gram, or microscopic hematuria, but each
decision was clinically made. Biopsy specimens were examined by
light, immunofluorescent, and electron microscopy. Pathologic criteria
were agreed on (Herdson et al N Z Med J 86:1—4, 1977). Active
treatment of ON (other than steroids for minimal change) was avoided,
but recorded if used, as was clinical and laboratory data at set intervals.
Enrollment ended in June, 1983, with 822 patients, including minimal
change (82 cases), focal glomerulosclerosis (87), IgA disease (104), focal
ON (101), acute post-infectious GN (80), mesangioproliferative GN
(81), type 1 mesangiocapillary GN (77), and membranous ON (84). So
far, 117 patients have begun dialysis, 44 are dead of renal failure, and 36
are dead of other causes. The usual effects of age on diagnosis, and of
age and diagnosis on outcome, were seen. It is intended to follow all
remaining patients until 1993, a minimum follow-up of ten years.
Polynesian patients were not greatly overrepresented in the study
group, nor was their outcome worse than that of the other races. IgA
disease, crescentic ON, and membranous ON were found to be very
uncommon in them, but they had a higher rate of post-infectious and
mesangiocapillary GN, as well as Ooodpasture's syndrome. This dis-
ease showed a non-uniform incidence with 14 of 38 cases occurring in a
two-year period. Differences in disease patterns were seen between the
centers; race did not explain this.
Continuous ambulatory peritoneal dialysis (CAPD): Six years experi-
ence in one center. N. M. Thomson, R. C. Atkins, S. R. Holdsworth, J.
Agar, D. F. Scott, and C. Wood. Department of Nephrology, Prince
Henry's Hospital, Melbourne, Australia. Following the introduction of
CAPD in 1976, the technique has gained widespread acceptance
throughout the world. However, the problem of peritonitis remains, and
some groups reported increased mortality with CAPD when compared
to hemodialysis (HD). Since June, 1978, we have trained 172 patients
with ESRF in the technique of CAPD. Our experience of CAPD in these
patients has been reviewed, paying particular attention to the changing
incidence of peritonitis in each year, the mortality and quality of life of
CAPD patients compared to 164 patients treated in the same period with
HD, and the outcome of renal transplantation in CAPD patients
compared to HD patients. The nature of the renal disease in CAPD was
comparable to that in HD patients except that 38 CAPD patients were
diabetic compared to six HD patients. The mean age of patients was
43.6 yrs (range: 5 to 74 yrs) for the CAPD group and 39.8 yrs (range: 9
to 68 yrs) for the HD group. The mean time spent on CAPD was 16.5
months (range: 2 to 75 months). Patient survival for CAPD and HD
groups was comparable, being 92 and 89% at 1 year and 78 and 75% at
3 years, respectively. Quality of life for non-diabetic patients was also
comparable for both groups. Fifty-one renal transplants have been
performed in patients on CAPD, with a 1-year graft survival for first
cadaver grafts of 62 compared to 55% for patients transplanted when on
HD. Survival of the technique of CAPD was 75% at 1 year and 52% at
3 years, compared to 82 and 65% respectively, for the technique of HD.
The incidence of peritonitis has fallen progressively from one episode
every 4.5 patient months in 1979 to one episode every 11.2 patient
months in 1984. It is concluded from our now extensive experience of
CAPD that this technique of dialysis is as effective as recurrent HD with
equal patient survival, quality of life, and outcome after transplantation.
Moreover, with time, there has been a progressive fall in the frequency
of peritonitis.
The immunochemical characterization of the light chains in the mesan-
gial IgA deposits in IgA nephropathy. K. N. Lai, K. W. Chan, C. P. Ho,
K. W. Yan, F. Mac-Moune Lai, and J. ValIance-Owen. Renal Unit,
Department of Medicine, Chinese University of Hong Kong, Prince of
Wales Hospital, Shatin, New Territories, Hong Kong. The im-
munochemical characterization of the light chains of the mesangial IgA
deposits was studied in 45 patients with IgA nephropathy. Kappa (K)
and Lambda (A) light chains were detected with direct immunofluores-
cence method, using monospecific rabbit anti-human, anti-kappa, and
anti-lambda light chains antisera. The glomeruli of 42 patients studied
were strongly positive for A light chain, while only 25 specimens were
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positive for K light chain. There is a predominance of lambda light-
chain-staining in the mesangial IgA deposits in these patients. The light
chain immunofluorescence patterns in 21 patients with systemic lupus
erythematosus (SLE), nine patients with idiopathic membranous
nephropathy (MN), and 25 normal renal biopsy specimens from post-
mortem examination were used as control. The results are summarized
in the table:
(Number of Group Group Group
patients) 1 2 3 P value
X>K A =K K>X (Single-sampletest)
IgA nephropathy 29 15 1 P < 0.001
SLE 8 9 4 P>0.05
MN 1 8 0 P<0.Ol
"Normal" autopsy renal biopsy specimens. No K or A staining in 25
specimens.
IgA nephropathy with predominant A light chain staining (Group 1) is
associated with a lower incidence of impaired renal function at the time
of biopsy (P < 0.05) when compared with the other two groups of
patients with IgA nephropathy. However, the group 1 patients did not
have a significantly different incidence of severe morphological changes
in their renal biopsy specimens, and their serum creatinine and creati-
nine clearance do not differ from the remaining patients (P = 0.15). The
results indicate that mesangial IgA deposits in IgA nephropathy consist
mainly of IgA with A light chains despite the normal ratio of K to A
containing immunoglobulin is two to one. IgA nephropathy with pre-
dominantly lambda light chain containing IgA may appear to have a
better prognosis.
Ultrastructural gold labelling of immune complexes and tissue antigens
in the human kidney. P. S. Smith. Institute of Medical & Veterinary
Science, Adelaide, South Australia. The aim of this study is to
demonstrate and analyze the ultrastructural localization of immune
complexes and tissue antigens in human renal biopsy specimens using
gold labelled antisera and lectins. This is achieved by post-embedding
labelling of thin resin-embedded tissue sections, a technique which has
not been previously possible with embedded tissue, allowing a variety
of antigens to be labelled using separate sections from one piece of
tissue. Gold particles provide a much clearer label than other
ultrastructural markers. There is no obscuring reaction product as there
is with peroxidase, and the particles are more electron dense than
ferritin, allowing easy quantitation. Portions of frozen tissue routinely
used for immunofluorescence are used for this study. These are fixed at
room temperature and processed at subzero temperatures into an
acrylic resin. The localization of immune complexes in various
glomerulonephritides correlates well with immunofluorescence, Using
labelled lectins, a number of sugar residues within the glomeruli and
tubules are demonstrated. However, the post-embedding localization of
more complex tissue antigens, for example, type IV collagen and
laminin, has not yet proved possible, as resin embedding appears to
block antigen recognition. Further developmental work is in progress to
rectify this problem. Gold labelling of antigens in thin sections has
provided a means to study deposition and handling of immune com-
plexes in renal disease. It also has the potential, with further develop-
ment, of elucidating the synthesis and structure of both normal and
diseased basement membranes.
Glomerular basement laminal (GBL) abnormalities associated with
idiopathic hematuria, M. Coleman, W. D. G. Haynes, P. Dimopoulos,
L. J. Barratt, and L. R. Jarvis. The Flinders Medical Centre, Adelaide,
South Australia, From 480 renal biopsy specimens reviewed recently,
41 cases have been identified in which glomerular basement laminal
(membrane) ultrastructural abnormalities were the major lesion. All
cases had hematuria. Subjectively, the GBL changes were variable, but
nearly always included laminal thinning. In a detailed morphometric
study of GBL thickness, 12 of these cases (study group) were compared
with (a) seven patients ("controls") with subjectively normal glomeruli
who were biopsied for reasons other than non-surgical hematuria, and
(b) four patients who presented with hematuria but who were also
thought to have normal glomerular ultrastructure. The results: the
seven controls had a mean GBL thickness of 394 nm (SD 19, range 356
to 432). Of the 12 study group cases, 11 had mean GBL thicknesses
significantly different from control values (nine exhibited mean GBL
thinning, range 235 to 327 nm; two showed thickening, means 440 and
469 nm). The remaining case had a normal overall mean, but showed an
abnormal distribution of very thin and very thick GBL regions. Of the
four apparently normal hematurics, significant mean GBL thinning was
demonstrated in three (326 to 347 nm), with an excess of thin GBL in
the fourth case, although the mean was normal. In conclusion, GBL
measurements confirm the subjective impression of a laminal abnormal-
ity, usually attenuation, as the principal finding in a group of hematuric
patients. Furthermore, morphometry may reveal subtle changes of
GBL thickness missed by subjective assessment.
Protamine sulphate-induced proteinuria: The roles of glomerular in-
jury and depletion of glomerular polyanion. A. Messina, D. J. Davies,
G. B. Ryan. University of Melbourne, Parkville, Victoria, Australia.
Proteinuria produced by the injection of protamine sulphate into the
renal artery has been explained as a direct effect of this strongly cationic
substance on glomerular polyanion. This concept has been re-examined
in rats in which urinary protein excretion was measured separately for
each kidney before, and for 60 to 90 mm after, injecting protamine
sulphate into the left renal artery. At the end of the experiment, both
kidneys were perfusion fixed for electron microscopy which included
assessment of the density and distribution of glomerular polyanion in
sections stained by a colloidal iron technique. In these experiments, 0,5
to 5.0 mg of protamine sulphate produced various degrees of protein-
uria, with the larger doses commonly causing oliguria. Electron micros-
copy showed degeneration and necrosis of tubules, and changes in the
glomeruli included formation of intracapillary aggregates of erythro-
cytes, fibrin and/or platelets, endothelial swelling, patchy loss of
epithelial foot processes, and scattered podocytic disruption leading to
focal areas of exposure of the outer surface of the glomerular basement
membrane to the urinary space. These changes were most severe with
doses of 2 to 5 mg of protamine sulphate, but were detectable with
doses as low as 0.5 mg. Staining of glomerular polyanion was
undiminished both on epithelial cells and the basement membrane, even
in areas of severe glomerular injury. We conclude that the injection of
protamine sulphate into the renal artery does not cause a reduction in
glomerular polyanion and the proteinuria observed can be attributed to
the effects of glomerular capillary wall injury.
Microwave fixation of renal tissue in clinical diagnostic studies. F.
Mac-Moune Lai, K. N. Lai, E. C. Chew, andJ. C. K. Lee. Faculty of
Medicine, Chinese University of Hong Kong, Shatin, New Territories,
Hong Kong. Microwave-fixed (MWF) renal biopsy material was stud-
ied by light microscopy (LM), immunofluorescence (IF), and electron
microscopy (EM) to assess the applicability of this method of fixation in
diagnostic histopathology. From eight patients who underwent diagnos-
tic renal biopsy, a small portion of tissue obtained was fixed by
microwaves and subsequently processed for LM, IF, or EM studies.
The remaining biopsy material was fixed and processed by routine
methods and used for comparison. A commercial microwave oven
delivering 2,450 MHz at 550 watts was used. Tissue placed in a beaker
containing 50 ml of normal saline at room temperature was irradiated
for 90 seconds to reach 60 to 70C and then immediately removed.
Post-fixed tissue was placed in upgrading alcohol for LM or 1% osmium
tetroxide for EM and processed routinely. For IF, the MWF tissue was
frozen-sectioned and directly stained using fluorescein isothiocyanate
conjugated antisera against immunoglobulins, complement, fibrinogen,
or light chains. In LM, the renal architecture, cellular and membrane
constituents were well preserved, as reported previously. Pathological
changes such as thrombosis, exudation, sclerosis, crescents, hyaliniza-
tion, and "wire-loop" lesions were well demonstrated and equivalent to
formalin-fixed tissue. IF staining of MWF tissue from cases of lupus or
IgA nephropathy clearly demonstrated immunoglobulins, complement,
or light chain deposits, the distribution and intensity of which were
similar to that of fresh-frozen tissue. The ultrastructure of the
glomerulus and tubule in both scanning and transmission EM were well
preserved following MWF. Lesions such as fusion of podocytes,
thickening of basement membrane, and electron-dense deposits were
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clearly revealed. The pathological changes and immunological features
were readily identified in MWF renal tissue. Microwave fixation can be
effectively applied in the processing of renal biopsy. The method is
rapid and allows delayed IF staining when tissue is sent to a referral
institution.
Comparative influence of hyperkalemia and steroid hormones on renal
potassium handling. M. J. Field and G. H. Giebisch. Department of
Physiology, Yale Medical School, New Haven, Connecticut, USA.
Changes in plasma potassium concentration, and in levels of mineralo-
and glucocorticosteroids, are known to influence renal potassium
excretion. However, the direct effect of each of these factors on
potassium transport in the distal tubule has not been precisely defined.
To address this issue, rats were adrenalectomized, given "basal"
replacement doses of aldosterone (Aldo) and dexamethasone (Dcx),
and studied by simultaneous clearance and microperfusion techniques 8
to 10 days later. Animals then received a background infusion of Ringer
(R) or KC1 (K), as well as an acute infusion of either Aldo or Dex, or
their vehicle (V). Measurements were made both of whole kidney
potassium excretion (UKV, moles/minI100 g), and of the net rate of
potassium secretion (JK, pmoles/min) into individual distal tubules
studied by microperfusion with a constant perfusion fluid at a fixed
perfusion rate (12.5 nllmin). Key results were as follows (means SEM,N = 12 to 17 tubules/six rats per group):
R+V R+ Aldo R+Dex
UKV:
JK:
0.5 0.1
62 8
0.5
113
0.1
6
0.8 0.1
64 6
K+V K+Aldo
UKV:
JK:
1.2 0.1
131
1.3 0.1
168
Conclusions: (I) Only hyperkalaemia and Aldo directly stimulate
distal tubular K secretion when luminal flow rate is held constant; (2)
UKV does not rise after acute Aldo because a concomitant fall occurs in
urinary flow rate, opposing the direct tubular effect; and (3) the increase
in UKV after acute Dcx is an indirect effect, due to stimulation by Dcx
of urinary flow rate.
The act of drinking completely inhibits vasopressin release in dehy-
drated sheep. J. R. Blair-West, A. P. Gibson, R. L. Woods, and A. H.
Brook. Howard Florey Institute of Experimental Physiology and Med-
icine, University of Melbourne, Parkville, and Baker Institute, Alfred
Hospital, Prahran, Victoria, Australia. Water-restricted sheep accu-
rately replace the water deficit in 2 to 3 mm of voluntary drinking and
conserve almost all of the water despite a fall in plasma vasopressin
(plasma AVP) to basal. The rate of fall in plasma AVP after drinking
suggests a rapid inhibition of vasopressin release via oropharyngeal
receptors. The degree of inhibition of vasopressin release after
rehydration was measured by comparing the decline in plasma AVP
after drinking with contrived plasma AVP disappearance curves. Sheep
were restricted to 500 ml water/day for 7 to 9 days and then offered
water. They drank 3.5 to 5.0 liters in 2 to 3 mm. Plasma AVP rose from
4.4 0.6 to 19.0 1.9 pg/mI during water restriction and fell to 7.5
0.4 pg/mI (P < 0.01) 15 mm after drinking, and 4.6 0.8 pglml after 1
hr. The same sheep were water loaded and AVP was infused i.v. for 1
hr. Infusion at 0.5 pg/hr increased plasma AVP from 3.2 0.4 to a
plateau of 19.0 1.2 pg/mI. After stopping infusion, plasma AVP fell to
8.3 0.5 in 15 mm and 3.9 0.3 pg/ml in 1 hr, almost identical with the
decline after drinking. A semilogarithmic plot of the disappearance
curves showed more than one component. The primary finding was that
the act of drinking to satiation completely inhibited vasopressin release,
preceding any fall in plasma osmolality. The question remains whether
incomplete satiation of thirst initiates the inhibitory mechanism.
Control of the renin-aldosterone system in primigravid human preg-
nancy. M. A. Brown, E. Nicholson, J. S. Prendergast, M. R. Ross and,
E. D. M. Gallery. Department of Renal Medicine, Royal North Shore
Hospital, St. Leonards, Australia. Normal pregnancy is characterized
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by plasma volume expansion, cumulative salt and water retention, and
stimulation of the renmn-angiotensmn-aldosterone (RAA) system. Few
studies have addressed the control of this system in pregnancy despite
the many alterations of its components reported in pregnancy-associ-
ated hypertension (P-AH). Twenty-three normotensive primigravid
pregnant women were randomized to a high-salt (>250 mmoles/day) or
low-salt (<50 mmoles/day) diet for seven days during both second and
third trimesters. Paired measurements were made before and after
dietary manipulation of plasma renin activity (PRA), plasma aldoster-
one concentration (Paldo), urinary aldosterone excretion (Ualdo.V),
plasma volume (PV), urinary sodium and potassium excretion (UNa;
UK.V), weight (wt), and mean arterial pressure (MAP). The results
are outlined in the table:
Low-salt
(N = 13)
Study
day
PRA
ng Al/ml/hr
Paldo
fmoles/ml
22 to 26 weeks 0
7
4.2 0.4
12.1 24b
1180 217
2097 3l9C
32 to 36 weeks 0
7
4.9 0.613.6 3.l 2124 4433553 419'
High-salt(N = 10)
22 to 26 weeks 0
7
4.8 0.8
3.2 0.8
1272 294
760 132
32 to 36 weeks 0
7
5.2 1.6
2.8 13b
2391 377
1093 126b
Low-salt Ualdo.V UNaW UKV
(N = 13) nmoles/day mmoles/day mmoles/day
22 to 26 weeks 421 68
872 1958
138 16
30 4C
76 7
67 4
32 to 36 weeks 685 149
1085 1728
112 10
31 4C
56 4
61 6
High-salt(N = 10)
22 to 26 weeks 365 29
171 29C
96 7
283 16C
57 9
64 8
32 to 36 weeks 637 88
267 63b
109 13
265 20C
67 9
68 10
Low-salt MAP A wt PV
(N = 13) mm Hg kg ml/cm
22 to 26 weeks 73 2
70 1 —1.4
22.3 0.6
21.9 0.7
32 to 36 weeks 74 2
78 2 —1.4
24.9 0.7
24,6 0.8
High-salt
(N= 10)
22 to 26 weeks 75 2
74 3 +1.3
22.0 0.9
22.5 0.8
32 to 36 weeks 80 2
84 3 +1.8
23.1 0.7
23.9 1.0
a p < b P < 0.01; P < 0.001 between day 0 and day 7.
These results demonstrate that: (1) the RAA system is stimulated
throughout pregnancy, with baseline aldosterone secretion rising as
pregnancy progresses; (2) plasma volume is "defended" but ECF
volume alters during dietary sodium manipulations; (3) the RAA system
responds appropriately to its sodium stimulus throughout pregnancy
but urinary K excretion does not alter; and (4) MAP is not significantly
altered by sodium loading or depletion. This study provides a basis for
prospective examination of RAA control in those destined for P-AH, a
disorder characterized by relative plasma volume contraction.
Anti-natriferic activity of autologous proximal tubular fluid of the rat
during isotonic saline volume expansion. A. Z. Gyory, M. Chan, and S.
Reddy. Department of Medicine, University of Sydney and Department
of Renal Medicine, Royal North Shore Hospital, St. Leonards, New
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South Wales, Australia. We have previously shown that during man-
nitol-saline volume expansion, autologous proximal tubular fluid inhib-
ited sodium transport in the rat, despite elevated peritubular osmolar-
ity. The present micropuncture experiments were carried out in male
Wistar rats during isotonic saline volume expansion. Isotonic volume
flux was inhibited 49% (P < 0.001) with harvested autologous proximal
fluid, but only 22% (P < 0.0001) with an artificial solution also, during
volume expansion. Similar results were obtained when sodium trans-
port was measured as the transepithelial sodium concentration differ-
ence across the proximal tubules under these conditions. Thus, both
isotonic water, as well as Na transport, are inhibited to the same extent
by autologous proximal fluid. These results, and those obtained previ-
ously with mannitol-saline volume expansion, indicate the presence of
a factor in proximal tubular fluid of volume-expanded rats which only
inhibits Na transport independent of peritubular osmolarity. This factor
is different from atrial natriuretic factor since the latter does not inhibit
proximal tubular Na transport.
Evidence for a voltage-dependent acidification defect in distal renal
tubular acidosis (dRTA) induced by amiloride (A). G. G. Allen, L.
Sherry, L. J. Barratt. Renal Unit, Flinders Medical Centre, Bedford
Park, South Australia. It has been proposed that some forms of Type
IV (hyperkalaemic) dRTA are due to a voltage-dependent acidification
defect in the collecting tubule in which distal H and K secretion are
decreased secondary to a reduced transepithelial potential difference
(PD) arising from impaired distal Na reabsorption. We have studied a
model of Type IV dRTA induced by A in rats to examine specifically the
effects of this drug on the PD of cortical collecting tubules (CCT) under
conditions favoring maximum distal proton secretion. Nine male Gin-
ger-hooded rats were studied: five served as controls (C) while four
were given A in a dose of 3 mg/kg/day for a minimum of 4 days prior to
micropuncture. Animals were pre-loaded with deoxycortisone acetate
and received 4% sodium sulphate intravenously at 2 mlihr throughout
all experiments. Results expressed as Mean SEM (N):
C A Cvs.A
GFR, mI/mm 2.1 0.2 (4) 2.0 0.1 (4) NS
Plasma K,
mmoles/liter 3.3 0.1 (5) 4.9 0.3 (4) P < 0.001
Fractional
excretion
K, % 37.4 2.3 (4) 11.2 3.1 (4) P < 0.001
Urine pH 5.55 0.05 (5) 6.35 0.07 (4) P < 0.001
CCT PD, mV —58.9 3.1 (28) —21.1 1.9 (26) P < 0.001
Conclusions: (1) A induces a significant acidification defect in rats. (2)
Urine K excretion is reduced by A. (3) The PD in CCTs is markedly
decreased by A. (4) These results support a voltage-dependent mecha-
nism operating in CCTs to explain A-induced dRTA.
Family studies in arteriolar C3 disease: A cause of benign familial
hematuria. M. A. B. Thomas, L. S. Ibels, J. V. Wells, and C. S. Lauer.
Department of Renal Medicine, Royal North Shore Hospital, St.
Leonards, Australia. Deposition of C3 in the glomerular afferent
arteriole has been described in association with the syndrome of
persistent primary renal microscopic or recurrent macroscopic
hematuria loin pain, with normal renal function and histology. To
investigate the prevalence of familial renal disease in this syndrome, 74
first-degree relatives of 26 patients with arteriolar C3 disease were
screened with one or more urine microscopies; all had normal creati-
nine clearances. Fifty children of 26 patients were screened. One or
more abnormal microscopy specimens were found in 56% of the
children, with hematuria in 46% and cast excretion in 46%. Twenty-four
parents of 15 patients were screened. One or more abnormal microscop-
ies were found in 79% of the parents, with hematuria in 54% and cast
excretion in 46%. Four relatives with persistent urine sediment abnor-
malities and normal renal function underwent renal biopsy. All demon-
strated intense granular deposition of C3 in the afferent arteriole, with
small vessel mural deposits in two. Arteriolar C3 disease has a familial
pattern consistent with autosomal dominant inheritance. Preservation
of normal renal function over three generations confirms the good
prognosis of this condition.
Renal autotransplantation for control of loin pain in arteriolar C3
glomerulonephritis. M. A. B. Thomas, L. S. Ibels, and A. G. R. Sheil.
Renal Unit, Royal North Shore Hospital, St. Leonards, New South
Wales, Australia. One-third of patients with the syndrome of
hematuria, C3 deposition in the afferent arteriole, and normal renal
function and histology may experience loin pain. Nephrectomies have
been described for control of pain followed by recurrence of pain on the
contralateral side. Three patients (2 male, 1 female, aged 19 to 28 years)
with arteriolar C3 disease and narcotic-requiring unilateral loin pain for
1 to 4 months underwent renal autotransplantation to the iliac fossa.
Pre-operative investigation excluded other known causes of loin pain or
psychological disturbance. All had received mild analgesia steroids
without effect, but had demonstrated transient relief from splanchnic
nerve blocks. All patients described immediate relief of pain post
operatively and were able to cease narcotics. Pain relief has persisted
for 2 to 5 months to the time of report with no technical complications.
Autotransplantation offers relief of otherwise intractable loin pain from
arteriolar C3 glomerulonephritis without loss of renal function, presum-
ably by achieving complete denervation.
Effect of oral penbutolol on renal hemodynamics of hypertensive
patients with renal insufficiency. R. R. Bailey, R. Carlson, C. P.
Swainson, and R. J. Walker. Department of Nephrology, Christchurch
Hospital, Christchurch, New Zealand. Penbutolol is a non-cardioselec-
tive /3-adrenoreceptor antagonist with intrinsic sympathomimetic activ-
ity. Most /3-blockers are associated with a fall in renal blood flow (RBF)
and glomerular filtration rate (GFR). In patients with renal insuffi-
ciency, this fall may be clinically significant. Preliminary studies have
suggested that oral penbutolol may increase the GFR of healthy young
men, and that a single 4mg i.v. dose of penbutolol had a favorable effect
on the renal hemodynamics of nine untreated hypertensive patients
with renal insufficiency. In this study, eight hypertensive patients with
stable chronic renal failure were given placebo for 21 days and then the
effective renal plasma flow (ERPF) and GFR were measured using a
double isotope method. These measurements were repeated after 4
weeks of treatment with oral penbutolol (40 to 80mg q 24 hr). Pulse rate
and blood pressure were monitored throughout. The mean results (±
SD) are included in the table:
Before After
Pulse rate (supine), 76.5 10.0 63.5 4.8
beats/mm (P < 0.001)
Mean arterial pressure
(supine), mm Hg 117 12.6 109 11.8
ERPF, ml/min/1.73 m2 217 136 217 124
GFR, ml/min/1.73 m2 50.1 28.8 48.6 25.9
Filtration fraction 0.24 0.04 0.24 0.05
Renal blood flow,
ml/min/1.73 m2 385 267 398 231
Renal vascular resistance,
mm Hg/ml/min/1.73 m2 0.51 0.38 0.38 0.23
The BP was lowered in all patients There was no adverse effect on
renal hemodynamics and a fall in the calculated mean renal vascular
resistance. These results suggest that penbutolol may allow indepen-
dent regulation of the renal circulation by direct renal vasodilatation.
Penbutolol appears to be a safe and effective /3-blocker for treating
patients with renal insufficiency.
Polynesian renal disease. C. Ross and T. J. Neale. Department of
Renal Medicine, Wellington Hospital, Wellington, New Zealand.
Polynesians treated for end-stage renal failure (ESRF) in New Zealand
greatly exceed their expected representation by population. Little is
known of reasons for this. We undertook a retrospective analysis of a
decade of Polynesian admissions to Wellington Hospital (1973—1982)
with a 'medical' renal tract diagnosis. Maoris (M) numbered 236 (116
males, 120 females) and Pacific Islander (P1) 93 (42 males, 51 females).
Glomerulonephritis (GN) occurred in 37.4%; the proportion of P1 with
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GN in both sexes exceeded M (male 54.8 vs. 42.2%), females 35.3 vs.
23.3%). Poststreptococcal GN accounted for 12.8% of all admissions; P1
exceeded M (21.5 vs. 9.3%), but there was no sex difference as evident
for M (males 16.4%, females 2.5%). Minimal change GN was exclu-
sively male; 11.9% P1, 2.6% M. No cases of familial nephritis and only
one each of analgesic nephropathy and anti-GBM antibody disease
were identified. Despite a high incidence of gout (25% M males, 10.8%
M females, 14.3% P1 males), gouty nephropathy was rare. Hypertensive
nephropathy was uncommon. Acute pyelonephritis was predominantly
a female diagnosis, and the most frequent reason for admission in M
women (16.7%). Reflux nephropathy was common in M women.
Diabetic nephropathy occurred only in M (5.2% males, 2.5% females).
Female P1 had the highest incidence of 'simple' calculi (17.6%) and a
further 9.8% had calculi and 'chronic pyelonephritis' (IVP, renal
biopsy, or nephrectomy histology). Male Pt were affected only half as
frequently and had a lower incidence of obesity (10 vs. 68%). Polycystic
kidneys occurred only in M and were uncommon. Ten percent of
patients presented in chronic renal failure for which no etiology was
established; 1.5% were end stage. P1 were younger at presentation and
had better outpatient attendance and medication compliance than M.
General Practitioner admissions were more frequent in P1 than M. A
quarter of M patients (but only 10.8% of P1) progressed to ESRD.
Differences exist between the Polynesian and the European in the
incidence of particular renal diseases leading to hospital admission, but
complex interactions between medical, sociological, cultural, and eco-
nomic factors appear likely to be responsible for the high frequency of
Polynesians on ESRD programs in New Zealand.
Low-protein and phosphate diet with keto acid precursors of essential
amino acids in children with chronic renal failure. K. F. Jureidini, L.
Daniels, G. N. Hill, R. J. Hogg, T. R. Southwood, and R. Vining.
Renal, Dietetics, Pharmacy, and Chemical Pathology Departments,
Adelaide Children's Hospital, Adelaide, South Australia. The effect of
a strict low-phosphate, low-protein diet with keto acid precursors of
essential amino acids is being evaluated in 18 children, aged between 15
months and 14 years, with glomerular filtration rate (GFR) between 12
and 45 mllmin/1 .73m2. All children previously had been treated with
conventional diet for at least 12 months, containing 2 glkg protein and
100 cals/kg expected weight for age. They all had oral bicarbonate to
normalize the serum bicarbonate, aluminum hydroxide binding gels
(alugel) with free dietary phosphate, and 1,25 dihydroxycholecalciferol
(1,25 DHCC) to raise serum calcium to the upper limit of normal and to
normalize serum alkaline phosphatase levels. On the altered diet, the
same 18 children have 1.2 g protein/kg protein and markedly reduced
dietary phosphate. Keto acid precursors of the essential amino acids are
added in a palatable orange-flavored drink (orange keto acid mix—
Sharp) or a sugar-coated granule form (Ketoperlen—Pfrimmer). There
has been no change in the dose of alugel or 1,25 DHCC. Monitoring of
the effectiveness of the diet is intense and includes both intact and
middle molecule parathyroid hormone (PTH) assays, monitoring of
growth, acceptance of diet, activity and psychological development, as
well as multiple biochemical analyses of blood and urine. The diet has
been well tolerated by all the children in the first 6 months of the study,
and 13 of the children have been observed by the parents to have
significantly increased activity and no change has been observed in the
other five. Growth velocity already has improved in 11 children. Intact
PTH levels have rapidly normalized in 16 children and lowered in the
other two. The mid-molecule PTH levels have lowered in all children
and totally normalized in one-half. Early results suggest that the diet
under study is well tolerated and improves the quality of life in children
with chronic renal failure. There is objective evidence of improvement
with normalizing of PTH levels and improved growth.
Colposcopic assessment of the lower genital tract in female renal
transplant recipients. A. B. MacLean, K. L. Lynn, R. R. Bailey, C. P.
Swainson, and R. J. Walker. Department of Nephrology, Christchurch
Hospital, and Department of Obstetrics and Gynaecology,
Christchurch Clinical School of Medicine, Christchurch, New Zealand.
Renal transplant recipients have an increased incidence of cutaneous
malignancy and cervical neoplasm. The incidence of epithelial or
cutaneous abnormality of the lower genital tract was studied in 31
women aged 35 9 years on renal replacement therapy for 1 to 184
months (mean 73). Twenty-four women had a renal transplant (two their
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second, one her third) and had received immunosuppressive therapy for
2 to 173 months (mean 61). At the time of study they were taking
prednisone 10 mg or less daily (one woman 17.5 mg/day) and
azathioprine 2.5—3.0 mg/kg/day. Seven women (two with failed trans-
plants) were on home hemodialysis (ito 48 months, mean 19) awaiting
transplantation. At a colposcopy clinic, a cervical or vaginal vault
smear was taken, followed by colposcopic assessment of the lower
genital tract. In 22 women (20 transplant, two dialysis), no abnormality
was found. One hemodialysis patient with a history of vulval warts 10
years previously had an extensive area of vulva! intraepitheial
neoplasia (vulval carcinoma in situ). Two transplant recipients had
perianal and vulval warts. Two transplant and one home dialysis patient
had smears with inflammatory changes plus the presence of wart
virus—human papilloma virus (HPV). Two transplant patients had
biopsy-proven HPV lesions of the cervical epithelium. The high inci-
dence of wart- (or HPV-) associated lesions in this group, and the
increasing evidence that HPV changes may predispose to cervical
neoplasia, suggest that this high-risk group require regular gynecologi-
cal assessment.
Treatment of bacterial cystitls with a single dose of trimethoprim,
co-trlmoxazole, or amoxydillin compared with a course of trlmethoprim.
R. R. Bailey, T. D. Keenan, J. C. Eliott, B. A. Peddle, and V. Bishop.
Department of Nephrology, Christchurch Hospital, Christchurch, New
Zealand. There is now impressive evidence that a single dose of an
appropriate antimicrobial drug is just as effective as the same drug used
for 5 to 10 days for the treatment of uncomplicated urinary tract
infections. This study assessed the efficacy of a single 600 mg dose of
trimethoprim, 1.92 g of co-trimoxazole or 3 g of amoxycillin compared
with a 5-day course (300 mg q 24 hr) of trimethoprim for the treatment
of women presenting in general practice with lower urinary tract
symptoms. Patients were randomly allocated to treatment before urine
culture results were available. The study was continued until 150
women had been enrolled. Bacteriuria was diagnosed if the voided urine
specimen had a bacterial count of> 100 x 106 organisms/liter, and cure
defined as a bacterial count of < 10 x 106/liter 5 to 9 days after
treatment. Women with abacterial cystitis, a bacterial count of 10 to 100
x 106/liter or those not completing the protocol were excluded. The
results are included in the table:
Trimeth-
oprim
stat
Co-tri-
moxazole
stat
Amoxy-
cihin
stat
Trimeth-
oprim
5 days
No. enrolled 37 37 37 39
No. excluded 17 12 14 18
No. completing study
(No. cured) 20 (16) 25 (20) 23 (15) 21(18)
No. resistant
pathogens 3 0 6 1
No. side effects 4 3 4 1
There was no significant difference between the four treatment
groups ( 2.97; 0.20, P < 0.30). Single-dose treatment of uncompli-
cated urinary infections has many advantages and should be considered
as the treatment of choice for bacterial cystitis or covert bacteriuria.
Risk of unlnephrectomy in humans: A 15 to 20-year follow-up. C. P.
Swainson. Christchurch Clinical School of Medicine, Christchurch,
New Zealand. The long-term risks of hypertension and proteinuria after
nephrectomy in humans are not known. A retrospective survey of
patients (< 65 years) who had uninephrectomy 15 to 20 years ago was
done. They were traced and the original notes and causes of death
reviewed. Living patients were contacted, and they gave a medical
history, weight, blood pressure, and blood and urine samples. 128
patients were traced, and complete data obtained on 119. 80% of
patients whose original operation was for renal carcinoma and 33% of
other patients had died, leaving 62 for study. 65% are healthy. 15% have
hypertension on treatment. Three were hypertensive at nephrectomy so
that six have developed hypertension. Two have 10 hyperpara-
thyroidism. One has hypercalcuria, one has cystinuria. Mean Ccr of
survivors was 1.35 0.45 mI/sec. but in 50% was < 1.5 mt/sec. A
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significant negative correlation exists between the present Ccr and age (r
= 0.59, P < 0.01) and present Ccr with age at operation (r = —0.86, P
< 0.001). Urinary protein/creatinine was normal in 58. Two had
proteinuria with renal impairment, one had hypertension, and one had
heart failure; one with proteinuria had a later 2/3 partial nephrectomy
for a 2° carcinoma. The GFR is 0.35 mI/sec and the urinary protein 0.8
g/24 hr. The risk of hypertension seems no different than in the normal
population and the risk of proteinuria related to either complicating
hypertension or extreme ablation of renal mass.
Nephrotic range proteinuria: A good predictive index of progressive
disease in IgA nephropathy? K. N. Lai, C. P. Ho, K. W. Chan, K. W.
Yan, F. Mac-Moune Lai, and J. Valiance-Owen. Renal Unit, Depart-
ment of Medicine, Chinese University of Hong Kong, Prince of Wales
Hospital, Shatin, New Territories, Hong Kong. Severe proteinuria in
IgA nephropathy, especially in nephrotic range, is reported to be
associated with progressive renal insufficiency and with severe renal
histopathological changes, although two recent studies did not find a
correlation between the severity of proteinuria and the clinical out-
come. IgA nephropathy with nephrotic range proteinuria is relatively
common in our patients. A combined retrospective and prospective
study of 86 patients with IgA nephropathy was conducted with the
purpose of determining if heavy proteinuria is a predictive index of
progressive disease. The patients were categorized into three groups:
Group A, 31 patients with proteinuria < 1 g/day; Group B, 31 patients
with proteinuria of I to 3.5 g/day; and Group C, 24 patients with
proteinuria > 3.5 g/day. These groups are comparable in the age of
presentation, sex ratio, and the duration of follow-up. There was no
difference in the serum creatinine, creatinine clearance, incidence of
hypertension, and incidence of impaired renal function. The group C
patients did not have increased incidence of progressive disease.
Nevertheless, they had a higher incidence of nephrotic syndrome (P <
0.001), a lower incidence of macroscopic hematuria (P <0.05), lower
serum albumin (P < 0.05), and heavier proteinuria (P < 0.01). The
seventy of proteinuria had no significant correlation with the severity of
renal pathological changes. The clinical picture divided these 24 pa-
tients with nephrotic range proteinuria into three clearly defined groups
with different prognoses. Six patients had progressive disease with
decreasing proteinuria. Five of them remained hypertensive and their
initial renal biopsy showed advance histopathological changes. Thirteen
patients had persistent proteinuria, yet the renal function remained
unchanged. Three were treated with steroid, but failed to respond.
Their renal histological changes were usually moderate. The remaining
five patients had good responses to steroid therapy, although two
became steroid dependent. Their renal histopathology showed mild
alterations. In conclusion, severe proteinuria in IgA nephropathy does
not inevitably indicate a poor prognosis.
The incidence and influence of renal failure in multiple myeloma. C. J.
Wood, P. Ellims, J. Agar, N. M. Thomson, and R. C. Atkins.
Departments of Nephrology and Haematology, Prince Henty's Hospi-
tal, Melbourne, Australia. Renal failure has long been recognized as
one of the major prognostic factors influencing long-term survival in
patients with multiple myeloma (MM). Recent publications have sug-
gested that an aggressive approach to the management of myeloma
patients with severe renal failure using intensive chemotherapy and,
when necessary, dialysis can often result in a significant improvement
in renal function and subsequent improved survival. Since 1971, 118
patients at P.H.H. Melbourne have been diagnosed as having MM. In
63 patients (53%), renal impairment was documented at some stage
during their course, with renal impairment and MM diagnosed simulta-
neously at the initial presentation in 37 of these patients (31% of all
myeloma patients). The course of these 37 patients has been reviewed,
especially as regards prognosis and benefit of measures to treat the
renal impairment and myeloma. Of the 37 patients, 14 (group A) had a
serum creatinine greater than 500 tmoles/liter and 23 (group B) had
serum creatinine levels between 120 to 500 jmoles/liter. The incidence
of hypercalcemia, hyperuricemia, sepsis, exposure to nephrotoxic
agents (for example, iv. contrast material), and patient survival has
been assessed and a comparison made between the two groups. There
was no difference in the incidence of sepsis, hyperuricemia, and
exposure to nephrotoxins between the two groups, but hypercalcemia
and hypovolemia were present more frequently in group B patients.
Seven patients in group A required dialysis. Significant improvement in
renal function occurred less commonly in group A patients (29% vs.
43% in group B). The mean survival of group A patients was 4.6
months, compared to 14.5 months for group B. Our findings reaffirm; (1)
the high incidence of renal failure in patients with MM; (2) that the
simultaneous diagnosis of MM and renal failure is common, and (3)
renal failure is a poor prognostic factor in patients with MM, despite an
aggressive approach to the treatment of the myeloma, and renal failure,
with the likelihood of significant improvement in renal function being
low,
Outcome of patients with lupus nephritis. R. J. Walker, K. L, Lynn, C.
P. Swainson, and R. R. Bailey. Department of Nephrology,
Christchurch Hospital, Christchurch, New Zealand. Renal involvement
is very common in systemic lupus erythematosus. The findings on renal
biopsy give the best guide to renal prognosis. Forty-three patients (36
female, seven males) with lupus nephritis who had a renal biopsy
between 1972 and 1984 were studied prospectively at least annually.
The patients ranged in age from 12 to 64 years (mean 30.4). The
indications for renal biopsy were proteinuria and/or hematuria in 24
(56%), the nephrotic syndrome in 11(26%), renal insufficiency in six
(14%), the acute nephritic syndrome and hypertension in one each. The
initial renal biopsy (WHO classification) showed diffuse proliferative
glomerulonephntis (GN) in 21, mesangial proliferative GN in seven,
focal proliferative GN in six, membranous GN in three, minimal change
lesion in three, and three were unclassified. Follow-up was for 1 month
to 12 years (mean 60 months). Twenty-seven patients were treated with
prednisone and azathioprine, ten with prednisone alone, and six re-
ceived no immunosuppressive therapy. Twenty-five patients (58%) are
still alive (one on hemodialysis, one with a renal transplant), 14 (33%)
have died (three after renal replacement therapy), and four (9%) have
been lost to follow-up. Seventeen patients were normotensive (BP <
140/90mm Hg) and six were on antihypertensive therapy. Eight patients
died from lupus or complications of immunosuppressive therapy (pneu-
monia [2], septicemia, endocarditis, pancreatitis, ruptured esophagus,
cerebral hemorrhage, pulmonary hypertension). One-half of the pa-
tients with diffuse proliferative GN are dead. The 5-year cumulative
renal survival was 72%. We found a higher than expected male
incidence of lupus nephritis, a 5-year survival rate similar to that of
other studies, and a poor prognosis for patients with diffuse prolifera-
tive GN.
Hyponatremia. D. Le Couteur, C. McTigue, and A. Z. GyOry.
Department of Medicine, University of Sydney, and Department of
Renal Medicine, The Royal North Shore Hospital, St. Leonards, New
South Wales, Australia. Hospital records for 1,177 admissions during
the month of June were reviewed to determine the prevalence, etiology,
and degree of recognition of hyponatremia (serum Na < 131
mmoles/liter) in a large Australian metropolitan hospital population.
Fifty-nine patients had hyponatremia, a prevalence of 12% with mea-
sured serum Na (or 5% of all admissions), and these were equally
divided between medical and surgical admissions. Hyponatremia was
recognized ("commented on") in only 10% of medical and 4% of
surgical cases, was not followed up in 42%, and 19% of patients were
discharged with hyponatremia. Twenty-eight percent of surgical pa-
tients developed hyponatremia post operatively, and, of these, "dilu-
tion" was deemed to be the cause in 84%. There was a significant
relationship between amount of "free water" (free of non-metaboli-
zable osmoles) administered (dextrose-water) and the level of serum Na(P < 0.01). In view of the incipient nature of the symptoms of
hyponatremia which can closely resemble, in their early phase, those of
cerebral atherosclerosis, more attention needs to be paid to this highly
prevalent and eminently treatable condition, especially in the elderly
where such symptoms might easily be ascribed to early dementia.
Two new potent quinolone carboxylic acid derivatives for the treatment
of urinary tract infections. R. R. Bailey and B. A. Peddie. Department
of Nephrology, Christchurch Hospital, Christchurch, New Zealand.
The search continues for more effective antimicrobial drugs for treating
urinary tract infections (UT!). Norfioxacin and enoxacin are orally
absorbed quinolone carboxylic acid derivatives (analogues of nalidixic
acid) with excellent in vitro activity against all urinary tract pathogens,
including the troublesome nosocomial organisms. The gram-negative
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spectrum of activity of these drugs exceeds those of the early
cephalosporins and is superior to the aminoglycosides and the third
generation cephalosporins in many respects. Three open studies have
been undertaken. (1) Norfioxacin (400 mg q 12 hr for 7 days) was used
to treat 12 women with bacterial cystitis and four with uncomplicated
acute pyelonephritis. One patient had an anaphylactic reaction to the
first dose. Of the remaining 15, 12 were cured (sterile urine 7 days alter
last dose). The failures included a woman with acute pyelonephritis,
another with recurrent cystitis due to Kleb pneumoniae, which had
become resistant to norfioxacin by day 4, and an elderly patient later
shown to have a unilateral shrunken kidney. One woman reported
nausea and another developed a mild, reversible neutropenia. (2)
Norfioxacin (400 mg q 12 hr for 7 days) was used to treat 20 patients
with a severe or complicated UTI (renal transplant, eight, neurogenic
bladder, four, paraproteinemia, three non-functioning kidney, two, and
miscellaneous, three. Ten were cured (4/10 Pseud spp, 2/5 Serratia spp,
2/2 Enterobacter spp, 2/3 E coli), eight had a relapse, and two became
reinfected with a resistant Strep fecalis. Two of these renal transplant
recipients with renal insufficiency developed a tendomtis. (3) Enoxacin
(200 to 400 mg q 12 hr for 7 days) was used to treat 25 patients with a
severe or complicated UTI. Eighteen were cured (14/18 E colt), five had
a relapse (four with major renal abnormality, one diabetic renal trans-
plant recipient) and two became reinfected with a resistant Strep
fecalis. Fourteen reported side effects, including six with neurological
symptoms, one with arthralgia, and one with Achilles tendonitis.
Comparative studies in patients with severe or complicated UTIs are
now indicated for these potent drugs, as well as an evaluation of their
optimal doses and duration of therapy.
Rapidly progressive glomerulonephritis: Treatment with combined
immunosuppression and anticoagulation with arvin. M. Segasothy, B. C.
T. Kong, Z. Murad, and A. B. Suleiman. Department of Medicine,
University Kebangsaan Malaysia, and Department of Nephrology,
General Hospital, Kuala Lumpur, Malaysia. The role of coagulation
mechanisms in the genesis or perpetuation of glomerular damage now
seems established. Fibrin deposition is involved in the formation of
extracapillary crescents. Defibrination with arvin has improved renal
function and decreased glomerular fibrin deposition in experimental
immune complex glomerulonephritis (Thomson NM et al, Clin Exp
Immunol 20:527, 1975). Arvin administration may have a role in
treatment of certain types of glomerulonephritis, especially lupus
nephritis in humans (Pollak VE et al, Am J Nephrol 2:195—267, 1982).
To evaluate the role of arvin combined with prednisolone,
dipyridamole, warfarin, and cyclophosphamide in the treatment of
rapidly progressive glomerulonephritis (RPGN), arvin was given for 14
days to five patients with RPGN, all of whom had impaired renal
function. Prednisolone, dipyridamole, and cyclophosphamide was
maintained throughout therapy. Warfarin was commenced alter arvin
was ceased. Three patients demonstrated improvement in renal func-
tion and alter follow up of 11 to 16 months continue to maintain
reasonable renal function, The patient with RPGN due to lupus
nephritis had significant improvement in renal function, but died as a
result of severe CNS involvement. One patient who presented with
severe renal failure did not respond to the combination therapy. There
were no significant side effects of arvin. It is concluded that defibrina-
tion with arvin in combination with prednisolone, dipyridamole,
warfarin, and cyclophosphamide has a role in RPGN. However, pa-
tients presenting with severe renal failure may not be improved.
Serum Tamm-Horsfall glycoprotein In normals and patients with renal
disease. R. J. Peach, J. S. Hunt, A. R. McGiven, and K. L. Lynn.
Department of Pathology, Christchurch Clinical School of Medicine
and Department of Nephroiogy, Christchurch Hospital, Christchurch,
New Zealand. Tamm-Horsfall glycoprotein (TH) is produced by a
discrete part of the distal tubule and released into the urine in amounts
of about 100 mg124 hr. A sensitive and specific enzyme linked im-
munosorbant assay (ELISA) utilizing monoclonal antibody THP/C4 has
been developed to detect TH in serum. Standard curves of urinary TH
demonstrated a sensitivity of 1 to 2 ng/ml with good plate to plate
reproducibility (c.v. <8%, N = 6). Sera from 196 normal blood donors
showed a mean value of 263 144 ng/ml with no significant age
correlation. Serum TH concentrations were measured in 39 patients (12
women, 27 men) aged 43 28 years with stable renal function (GFR
0.06 to 2.7 mI/sec) admitted for investigation of renal disease, and five
patients (four women) aged 16 to 63 years with acute renal failure (ARF)
(GFR < 0.45 ml/sec). Patients with stable renal function had TH
concentrations of 39 to 1290 ng/ml (mean 345 310 ng/ml). There was
a positive correlation between serum TH concentration and GFR (r =
0.70, P < 0.01). Patients with ARF had disproportionately high serum
TH concentration of 505 to 750 ng/ml. One anephric patient studied on
six occasions had no TH detectable in serum. Serum TH concentrations
were measured in 16 patients (three men), aged 35.9 19 years, with
acute pyelonephritis and plasma creatinine of 0.12 0.11 mmoles/liter,
from presentation for periods of up to 150 days. At presentation, the
mean TH concentration was 432 280 ng/ml (P < 0.001 of normal).
There was no correlation between plasma creatinine and TH concen-
trations (P > 0.1). Subsequent changes in TH concentrations were
variable with eight patients exhibiting a marked fall within the first 1 to
2 weeks. TH levels were normal by 50 days in 10 of 13 patients studied.
Results indicate further studies are required to investigate relationships
between physiological changes and serum TH levels in health and
disease.
The clinicopathological associations of mesangial IgA nephropathy. N.
W. Boyce, S. R. Holdworth, N. M. Thomson, and R. C. Atkins.
Departments of Medicine and Nephrology, Prince Henry's Hospital,
Melbourne, Australia. The clinicopathological correlations in 112 pa-
tients with primary IgA nephropathy are reviewed. To determine the
significance of macroscopic hematuria in the population (pop's), a
specific comparison was made between patients with a history of
macroscopic hematuria and those with only microscopic hematuria.
Overall mean age 38.3 years (90 males, mean 40.2 years: 22 females,
mean 30.2 years). Class I disease (mesangial matrix expansion alone)
occurred in nine (8%); Class II disease (diffuse mesangial proliferation)
occurred in 43 (38%); Class III disease (focal and segmental prolifera-
tion) occurred in 60 (54%), including subsets of 20 patients (16%) with
segmental necrosis, sclerosis and/or synechiae and 23 patients (2 1%)
with crescent formation. Class III was associated with more severe
renal impairment (mean serum creatinine Class III 209 M/liter cf. Class
1113 MM/liter and Class 11116 M/1iter) and an increased incidence of
hypertension (Class III 52% cf. Class I 33% and Class II 28%). There
were no significant correlations between histological class and urinary
protein excretion (pop" mean 1 .5g/24 hr), the incidence of nephrosis
(9.8% pop"), elevated serum IgA levels (49% pop") or history of alcohol
excess (26% pop"). Patients with macrohematuria (N = 42) differed
from those with microhematuria (N = 70) in that they were younger
(31.6 14.4 years cf. 43.1 16.7 years), had less severe renal
impairment (mean Cr 116.2 82.6 SM/liter cf. 213.3 217,4 iLM/liter)
and had a lower percentage of Class III biopsies (48% cf. 58%).
Crescents occurred in seven (17%) of those with macrohematuria and
16(23%) of those with microhematuria. Eventual progression to ESRD
correlated with crescentic disease (relative risk 5.42), but not with
macroscopic hematuria (relative risk 0.35). Thus, Class III histological
changes are predicted by the degree of renal impairment, and are
associated with a significantly increased incidence of hypertension.
This study shows no adverse clinical, histological, or prognostic corre-
lates of episodes of macroscopic hematuria. In particular, there was no
association between macroscopic hematuria and Class III disease or
crescent formation.
Renal disease in systemic lupus erythematosus: Prevalence of mild
disease and tubular function abnormalities. M. A. B. Thomas, L. S.
Ibels, D. C. Harris, A. Z. Gyory, J. Webb, C. S. Lauer, andf. V. Wells.
Departmentts of Renal Medicine, Rheumatology, Immunology and
Anatomical Pathology, Royal North Shore Hospital, St. Leonards,
New South Wales, Australia. To study the prevalence, clinical features,
renal tubular function (RTF), and prognosis in different histological
classes of lupus nephritis (LN), all patients with SLE referred to the
Renal Unit in 1977—1982 underwent investigation and biopsy. There
were 61 females aged 18 to 77 (mean 33.0) years and 15 males aged 16
to 76 (mean 54.1) years (P < 0.001). WHO histological class was I
(normal) in none, ha (EM/IF deposits) 17, JIB (mes. prolil.) 45, III
(focal prolif.) five, IV (diffuse prolif.) three, V (memb.) one, VI (diffuse
sclerosis) one, and non-SLE lesions four. Comparing mild LN (hA/JIB,
N = 62) vs. severe LN (Ill-VI, N = 10), the prevalence of hypertension
was eight vs. five (P <0.05), Ccr 98.1 25.2 vs. 81.0 36.7 mI/mm (P
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<0.01), proteinuria 12 vs. nine (P < 0.001), hematuria 18 vs. nine (P <
0.001), heavy cast excretion three vs. four (P < 0.01) and hematuria
any casts 42 vs. 10 (NS). RTF tests were abnormal in 72% patients (N
= 60) with max Uosm abnormal in 50% at 723 87 (N: 836 68)
mOsm/kgH2O, PSP excretion abnormal in 19% at 47 13 (N: 64 to 139)
% of dose, corrected for GFR, mm UpH abnormal in 23% at 5.7 0.6
(N < 5.2), NH4/Titratable acid excretion abnormal in 38% at 50.0 7,2
(N> 60%). There was no correlation with histological tubulointerstitial
changes, TBM, or peritubular Ig deposition or sicca features. Follow-up
on 70 patients after 3.3 1.5 years showed improved renal function in
IS, stable in 45, and worsened in 10. None developed ESRD; four died.
In mild LN, seven (11%) with worsened renal function did not differ
from 39 with stable function in initial clinical, histological parameters,
or treatment. Serial biopsies in eight showed good correlation with
changes in histological class, creatinine clearance, and urine protein
loss. LN is present in 100% of patients, mild in 86%, and associated
with RTF abnormalities in 72%. Severe versus mild LN cannot be
absolutely distinguished on clinical criteria, and 11% of mild LN may
progress.
Demonstration of glomerular lymphocyte infiltration In experimental
glomerulonephrltls. P. G. Tipping, T. J. Neale, and S. R. Holdsworth.
Departments of Medicine, Prince Henry's Hospital, Melbourne, Aus-
tralia, and Wellington Hospital, Wellington, New Zealand. Late phase
injury in preimmunized rat anti-glomerular basement membrane (anti-
GBM) glomerulonephritis (ON) has been shown to be due to macro-
phages. Cell-mediated immunity may be involved in their accumulation,
but lymphocytes have not been demonstrated at the site of injury. The
participation of T lymphocytes and their relationship to macrophage
accumulation was studied in this preimmunized model. Lymphocytes
were sought by indirect immunofluorescence using specific monoclonal
antibodies (Sera-Lab clones W3/13, W3/25, and 0x8) and electronmi-
croscopy, and could be demonstrated in glomeruli by both techniques.
Macrophage influx was assessed by glomerular cell culture, cytochemi-
cal staining for non-specific esterase, and electronmicroscopy. T cell
appearance was maximal 24 hr after administration of the anti-GBM
antibody (2.2 1.7 SEM cells per glomerular cross section, c/gcs). This
preceded the maximal macrophage accumulation (19.8 3.7 cells per
glomerulus) which occurred 2 days later and coincided with the peak of
glomerular hypercellularity (71.5 1.3 c/gcs) and proteinuria (242
27.9 mg/24 1w). Treatment with cyclosporin A, an anti-T cell agent,
prevented the appearance of glomerular T cells, subsequent macroph-
age accumulation, and glomerular injury. T cells were not seen in
glomeruli of rats during the heterologous phase of anti-GBM ON, nor in
preimmunized rats injected with nonimmune serum. These results
demonstrate infiltration of T cells into glomeruli during the autologous
phase of anti-GBM ON, and the timing suggests that they may be
involved in initiating the subsequent macrophage accumulation and
glomerular injury.
Immunoregulation in Heymann's nephrltls: Cellular requirement for
induction. I. K. P. Cheng, S. E. Dorsch, and B. M. Hall. Department of
Pathology, University of Sydney, and Renal Unit, Royal Prince Alfred
Hospital, Sydney, New South Wales, Australia. Heymann's nephritis(HN) is an autoimmune glomerulonephritis induced in rats by s.c.
injection of renal tubular antigens (RTA) emulsified in Freund's com-
plete adjuvant (FCA). The humoral response that leads to glomerular
injury in HN has been extensively studied. However, there is little
information on the cellular basis for the induction and maintenance of
this nephritogenic immune response. The studies reported in this paper
provide direct evidence that the induction of HN is T cell dependent,
requiring the presence of the W3/25 helper T cell subset. Male PVG
rats approximately 3 to 6 months old were used in all experiments.
T-depleted rats used as recipients in subsequent adoptive transfer
experiments were prepared by adult-thymectomy followed by lethal
irradiation and reconstitution with T-depleted bone marrow (ATXBM
rats). T lymphocytes and various T cell subsets were separated by a
modified "panning" technique and were adoptively transferred into
groups of ATXBM animals which were simultaneously challenged with
RTA in FCA. Disease development was monitored by serial measure-
ment of circulating anti-RTA autoantibody titers in scm, im-
munofluorescence microscopy for rat immunoglobulin and complement
(C3) in renal biopsy specimens, and 24-hr urine protein excretion.
ATXBM animals give no cells and those give 1g3/25 pooled spleen
cells (SC) and lymph node cells (LNC) failed to develop the disease.
However, ATXBM animals given either 1g or IgOX8SC and LNC
developed the disease with the same tempo as sham-thymectomized
control animals. It was therefore concluded that the induction of HN is
T cell dependent, requiring the presence of the 3/25k helper T cell
subset.
linmunoregulatlon in Heymann's nephritis: Modulation by suppressor
T cells. I. K. P. Cheng, S. E. Dorsch, and B. M. Hall. Department of
Pathology, University of Sydney, and Renal Unit, Royal Prince Alfred
Hospital, Sydney, New South Wales, Australia. It has previously been
shown that suppressor cells may be involved in the modulation of
Heymann's nephritis (HN), but the nature of the suppressor cell has not
been investigated. Adult thymectomy (ATX) has been shown in other
experimental systems to enhance the immune responses due to the
removal of a suppressor T cell population. We investigated the effect of
ATX on the induction of HN and its effect on the generation of
suppression using the same protocol described by previous workers.
ATX was found to significantly enhance HN development in PVO rats.
To confirm that this is due to the removal of a suppressor cell
population, groups of ATX animals were given thymocytes (TC), spleen
cells (SC), and lymph node cells (LNC) obtained from normal animals
and simultaneously given RTA in FCA. Reconstitution with TC and to
a lesser extent SC or LNC decreased the susceptibility of ATX animals
to nephritis induction. This confirmed that the effect of ATX was a
consequence of the removal of a suppressor cell population. The
efficacy of TC compared to SC and LNC suggested that the suppressor
cell is a T lymphocyte. The role of thymus-derived suppressor cells in
the modulation of the inmune response to renal antigens was further
confirmed using an alternative experimental system. Pre-immunization
of rats with RTA in Freund's incomplete adjuvant (FIA) stimulates a
suppressor cell response which renders the animals resistant to subse-
quent induction of nephritis with RTA in FCA. It was found that ATX
prevented this specific suppressor cell response, but the effect of ATX
was dependent upon the timing of preimmunization with RTA in FIA.
Mononuclear leucocyte composition of kidneys and peripheral hood in
experimental focal glomerular sclerosis (FGS). T. Saito, D. H. Hooke, N.
M. Thomson, and R. C. Atkins. Department of Nephrology, Prince
Henry's Hospital, Melbourne, Australia. Subpopulations of mononu-
clear leucocytes have been studied in kidneys and peripheral blood of
rats with progressive FOS induced by puromycinaminonucleoside
(PAN) and protamine sulfate (PS). FOS was induced in uninephrectom-
ized 10 to 12-week-old male rats by 16 repeated injections of PAN and
PS over 46 days. Rats were sacrificed at day 80. Kidneys were fixed
with PLP and frozen. Peripheral blood samples were collected from the
tail vein and leucocytes were separated on Ficoll-Isopaque gradients.
Cryostat sections (6 m) and smears of leucocytes were stained by a
two-layer PAP method with monoclonal antibodies against rat
leucocyte surface antigens; common leucocyte (OXl), Ia(0X4), T-
lymphocyte (W313, 0X19), helper T cell (W32S), suppressor T (0X8),
subgroup of helper T + suppressor T + B cell (0X22). In glomeruli, no
increase was seen in either the total number of leucocytes or in subsets
of leucocytes. However, prominent accumulations of leucocytes were
seen in the interstitial lesions of the animals with FOS. The number of
each subset of leucocytes, except 0X8 positive cells, was increased at
least fivefold over the number in the interstitium of control animals
(normal rats or rats receiving saline alone). The increase in 0X8
positive cells was only twofold. The proportion of 0X19 positive cells
(of all leucocytes) rose from 25% (before injection) to 40%, while 0X8
positive cells fell from 19 to 6%. In peripheral blood of animals with
FGS, a significant increase in the ratio of W3J2S to OX8 (helper T cell
to suppressor T cell) was seen, being 1.78 0.10 (mean SE, N = 4)
on day 80 compared to 1.44 0.22 (N = 5) in saline group and 1.21
0.50 (N = 8) in non-treated animals (P = 0.05) This finding of an
interstitial leucocyte infiltration, including helper T-lymphocytes and Ia
positive cells, suggests that cell-mediated immune mechanisms play a
part in the progression of this model of FGS which is induced by a
non-immune mechanism. This conclusion is further supported by the
finding of an increased helper Tisuppressor T cell ratio in the peripheral
blood.
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Left ventricular function in uremia: Echocardiographic and radionu-
clide assessment in patients on maintenance hemodlalysis. K. N. Lai, J.
Ng, J. Whitford, I. Buttfield, R. G. Fassett, and T. H. Mathew. Renal
Unit, The Queen Elizabeth Hospital, Woodville, South Australia.
Echocardiography and radionucide ventriculography were performed
in 37 uremic patients on maintenance hemodialysis with no apparent
coronary artery disease, pericardial effusion, valvular heart disease, or
heart failure. These non-invasive studies were performed during the
interdialytic period (about 18 hr after a dialysis). Sixty-two percent of
our patients had abnormal left ventricular function with one or more
abnormal echocardiographic parameters. The significant abnormalities
were enlargement of the left ventricular cavity, a reduction of myocar-
dial contractility, and thickening of the left ventricular posterior wall.
Measurement of cardiac index and ejection fraction were found to be
inadequate for full assessment of left ventricular function and other
parameters such as the mean velocity of circumferential fiber shorten-
ing and mean normalized posterior wall velocity should also be mea-
sured. There is a significant number of hemodialysis patients (7/37) with
congestive cardiomyopathic features on echocardiography. Their clin-
ical features are no different from the other patients in this study except
they have a significantly higher prevalence of uremic hyperpara-
thyroidism. Our findings support the existence of a specific uremic
cardiomyopathy, and uremic hyperparathyroidism may play an impor-
tant role in the pathogenesis.
Pulmonary function and exercise capacity in continuous ambulatory
peritoneal dialysis (CAPD) patients. C. R. W. Beasley and T. J. Neale.
Department of Renal Medicine, Wellington Hospital, Wellington, New
Zealand. The influence of the instillation of two liters of intraperitoneal
fluid on pulmonary function was studied in 20 unselected, well-estab-
lished CAPD patients (mean age 49 years, range 23 to 68) with a variety
of cardiorespiratory conditions. Eighteen of the subjects, in addition,
underwent a progressive load treadmill exercise test with the abdomen
both full (F) and empty (E), to assess work capacity. There was a
significant reduction (P < 0.01) in the mean functional residual capacity
(FRC), (2.92 liter (E) to 2.51 liter (F)), due to diminution in both the
mean residual volume (RV), (2.09 liter (E) to 1.89 liter (F) ) and
expiratory reserve volume (ERV), (0.82 liter (E) to 0.62 liter (F)).
However, there was no significant change in the vital capacity (VC), as
the mean inspiratory capacity (IC) increased from 2.28 liter to 2.52 liter.
There was a small reduction in mean total lung capacity (TLC) from
5.20 liter to 5.03 liter, but no significant difference in FEV1 or FEV1IVC
ratio, diffusing capacity, small airways function, or inspired gas distri-
bution. Mean V02 max was considerably reduced with the abdomen
empty (14.5 mI/kg/mm) compared with matched controls (33.6
mlikg/min); there was no significant change in the V02 max or heart
rate at submaximal work loads, with the peritoneal cavity full. Venti-
lation at submaximal work rates was significantly higher in CAPD
patients compared to controls (25.8 vs. 17.7 liter/mm at a work rate of
0.75 liter/mm). The majority of CAPD patients stopped the exercise test
for lower limb muscular symptoms. We conclude: (1) the instillation of
two liters of dialysis fluid in CAPD patients with cardiorespiratory
disease does not result in a clinically significant deterioration in
pulmonary function; (2) physical fitness is poor in unselected CAPD
patients, but the presence of intra-abdominal dialysis fluid does not
affect physical work capacity further. It is likely that, as has been
shown in hemodialysis patients, a program of exercise training would
improve cardiovascular and metabolic function in CAPD patients.
Serum oxalate in patients with chronic renal failure Is raised and is
higher in patients on dialysis. M. Wallace and N. France. Renal Unit
and Department of Chemical Pathology, Waikato Hospital, Hamilton,
New Zealand. Using an oxalate oxidase method modified from that of
Sugiura (France, Wallace, Cliii Chim Acta, in press), serum oxalate
levels in fasting overnight blood were measured in 36 controls, 18
patients in chronic renal failure (CRF) not on dialysis, 23 patients on
maintenance hemodialysis (MHD), and 24 patients on continuous
ambulatory peritoneal dialysis (CAPD). Overnight peritoneal fluid
oxalate levels were measured in those on CAPD.
For patients on CAPD, the peritoneal fluid oxalate level (overnight)
was closely correlated with serum levels (r = 0.8287, P < 0.001). It is
possible that acetate and lactate absorption during MHD and CAPD
account for the paradox of a higher serum oxalate in patients on
N
Mean serum oxalate,
jsmoles/liter SD
Controls (36) 13 5
CRF (18) 20 12 P < 0.05 t 2.0388
MHD (23) 30 10 P < 0.001 t = 9.0744
CAPD (24) 33 10 P < 0.001 t = 7.5707
dialysis. High serum oxalate is a risk factor for secondary oxalosis in
patients with chronic renal failure, and regular serum monitoring should
be part of routine care.
A new kidney preservation solution. B. Howden, P. Jablonski, C.
Harrison, G. Rigol, V. C. Marshall, and J. Tange. Department of
Surgery, Monash University, Melbourne, Victoria, Australia. Earlier
studies have indicated that beneficial preservation solutions for ice-
storage of kidneys must provide good buffering and an impermeant.
This study examines the effect of ice-storage with a solution (PBS) that
contains only phosphate buffer and sucrose (Na 126, phosphate 82,
sucrose 100 mmoles/liter, pH 7.1, 300 mOsm/kg). Ice preservation for
24 hr was studied with heterotopic kidney transplantation into isogeneic
rats and immediate nephrectomy of recipient kidneys. PBS-preserved
kidneys were compared to kidneys preserved with isotonic citrate
(IC-Na 78, K 84, Mg 40, citrate 54, sulphate 40, mannitol 100
mmoles/liter, pH 7.1, 300 mOsm/kg), isotonic citrate sucrose (ICS-
electrolytes as above, sucrose 100 mmoles/liter), hypertonic citrate
(HC-IC plus 100 mmoles/liter mannitol, 400 mOsm/kg), hypertonic
citrate sucrose (HCS-ICS plus 100 mmoles/liter sucrose), and
hypertonic PBS (HPBS-PBS plus 100 mmoles/liter sucrose). All the
hypertonic solutions were found to be detrimental, and the substitution
of sucrose for mannitol had no significant effect. Isotonic solutions
produced uniformly good survival (IC = 8/8, ICS = 7/8,PBS 7/8), and
surviving animals had good renal function 2 weeks after transplantation.
PBS-treated kidneys had similar function to those in the IC or ICS
groups. This study confirms that the essential components for good
preservation solutions are iso-osmolarity, an impermeant solute, and a
good buffer. These can be supplied by a simple solution such as PBS.
Cyclosporin A (CyA) and the lschemlc kidney. V. C. Marshall, P.
Jablonski, C. Harrison, B. Howden, D. Rae, G. Rigol, and I. Tange.
Department of Surgery, Monash University, Melbourne, Victoria,
Australia. Nephrotoxicity attributable to CyA represents a most signif-
icant problem in patients treated with this drug. In the rat, extremely
large doses of CyA (> 60mg/kg) are necessary to produce such effects.
It is suggested that acute tubular necrosis (ATN) may potentiate the
nephrotoxicity of CyA. Therefore, the effect of CyA was studied in rats
with graded ATh. ATN was produced by occlusion of the right renal
artery in male SD rats (0,30, or 60 mm) and left nephrectomy. CyA (25
mg/kg in olive oil) or oil (1 mI/kg) was given by gavage daily for 2 days
prior to warm ischemia and for 14 days thereafter. Other control groups
received no treatment. CyA-treated rats had significantly greater weight
loss than oil-treated or control rats. This was probably due to a reduced
food intake. In the group with severe ATN (60 mm ischemia), CyA-
treated rats had significantly higher (P < 0.02) serum creatimne and
urea concentrations at all times when compared to oil-treated or control
animals. Hypertrophy of the kidney was markedly reduced in CyA
animals (49 8% cf with 81 6% in oil group) and the degree of
morphological damage was greater. Serum bilirubin and alkaline phos-
phatase were significantly elevated (P < 0.001) in CyA-treated rats.
These results suggest that CyA has nephrotoxic, hepatotoxic, as well as
general debilitating effects.
Preservation of renal function in the rat remnant kidney model of
chronic renal failure by blood pressure reduction. B. Jackson, R.
Cubela, and L. Debrevi. Monash University Department of Medicine,
Prince Henry's Hospital, Melbourne, Australia. Adult rats were subject
to l/8 nephrectomy (Nx). Plasma creatinine (smoles/liter) rose progres-
sively from 65 16 (pre Nx, N = 17) to 153 27 over 6 weeks (P <
0.001). Serial histological studies showed glomerular lesions from 2
weeks post Nx. Glomeruli were enlarged, with mesangial expansion
and segmental areas of glomerulosclerosis. Glomeruloscierosis was
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generalized by 6 weeks post Nx, associated with marked
tubulointerstitial damage. Rats were treated with enalapril (5 mg/kg/day
in drinking water, N = 12), hydralazine (30 mg/kg/day, N = 6)one week
post Nx, and their course compared with untreated Nx rats (N = 17).
Blood pressure (awake tail cuff method, mm Hg) was lower with
treatment (at 6 weeks, untreated 176 7; hydralazine 137 6 (P <
0.005); enalapril 122 5 (P < 0.001)). Four untreated rats died of
uremia, but no enalapril- or hydralazine-treated rats died. Plasma
creatinine was lower in treated rats (at 6 weeks, untreated 152 27;
hydralazine 130 9; enalapril 110 8, P < 0.05). Indwelling arterial
and venous lines were inserted 6 weeks post Nx, and 51Cr EDTA and
1251 hippurate clearances measured in the awake unrestrained rat.
Filtration fraction (51Cr EDTA/'251 hippurate clearance) was higher in
untreated (0.35 0.05, N = 8) than enalapril (0.19 0,02, N = 8, P <
0.005) or hydralazine (0.19 0.03, N = 3, P < 0.05) rats. Glomerulo-
sclerosis (assessed by blinded histology score) was markedly reduced in
enalapril- and hydralazine-treated rats, as was urinary protein excretion
(mg/24 hr; untreated, 85 22; enalapril, 15 3, P < 0.001; hydralazine,
11 2, P < 0.01). Functional and structural damage in the rat remnant
kidney model of chronic renal failure was ameliorated by reduction of
blood pressure. This was associated with a lower filtration fraction.
The effect of cyclical hormonal changes and of pregnancy on erythro-
cyte-electrolyte transport mechanisms. E. D. M. Gallery, M. A. Brown,
R. Grigg, and J. Rowe. Department of Renal Medicine, Royal North
Shore Hospital, St. Leonards, New South Wales, Australia. Changes in
several aspects in erythrocyte cation transport have been described in
hypertensive subjects, results conflicting from different authors and
more variable from female than male subjects. This study's aim was to
investigate effects of hormonal changes induced in erythrocyte trans-
port parameters by ovulation, combined oral contraceptives, or preg-
nancy. Subjects were 65 normotensive volunteers: (1) male (N = 13),
(2) ovulatory women (non 0/C, N = 10), (3) women taking combined
oral contraceptives (0/C, N = 10), (4) women in second (P2, N = 19),
and (5) third trimester of their first pregnancy (P3, N = 13). Groups (2)
and (3) were studied at days 7 through 10 and 15 through 18 of a
menstrual cycle. All incubations were performed in artificial media, on
washed erythrocytes, with Rb as a K analogue. There were no cyclical
variations in groups (2) and (3). Active, NaJK ATPase-dependent
(ouabain-sensitive) Rb influx was significantly suppressed in 0/C, but
unchanged in pregnancy. Co-transpot (ouabain-resistant, furosemide-
sensitive Rb influx) was lowest in non-0/C, highest in male subjects,
with values midway for both 0/C and pregnant women, while passive
leak (ouabain- and furosemide-resistant Rb86 influx) was higher in all
female than male subjects (Table).
N
Male
13
Non 0/C
10
Rb influx,
nmoles/lOa cells
Ouabain-sensitive 184 6.8 183 6.9
Furosemide-sensitive 56 5.6 28 2,5b
0- + F-resistant 13 1.6 29 18b
N
0/C P2
10 19
P3
13
Rb influx,
nmoles/1O° cells
Ouabain-sensitive 163 7.2° 187 7.5 190 7.2
Furosemide-sensitive 42 4.2 43 4.7 48 4.3
0- + F-resistant 25 12b 28 l.2' 28 19b
a P<o.os; b P<0.00l.
There are clear cut sex differences in passive leak and co-transport,
with further alteration due to oral contraceptives and to pregnancy. The
co-transport differences may represent an in vivo androgenic effect of
19 nortestosterone derivatives in 0/C, and perhaps similar progesterone
metabolites in pregnancy. They are not explicable as aldosterone
effects. These hormonal effects must be taken into account in any
consideration of abnormalities, for example, in hypertensive subjects.
Renal function during angiotensin converting enzyme (ACE) inhibition
in renovascular hypertension in humans. B. Jackson, P. G. Matthews,
C. C. Wong, and C. I. Johnston. Monash University Department of
Medicine, Prince Henry's Hospital, Melbourne, Australia. Renal func-
tion was measured sequentially in 32 patients with renovascular hyper-
tension (RVH), treated with captopril. Eight episodes of acute renal
failure were seen in six patients. The acute rise in serum creatinine
(SCr) was not related to the degree of hypotension following captopril,
plasma angiotensin II levels, or concurrent diuretic use. Acute renal
failure was only seen in patients with bilateral renal artery stenosis
(three of 13 cases) or a single kidney with renal artery stenosis (three of
eight cases). Fouteen further patients with RVH were studied with
estimation of split renal function by mTcDTPA clearance (TcCI,
mllmin) before and after ACE inhibition by captopril or enalapril. In six
patients with unilateral renal artery stenosis, total TcCl and SCr
remained constant following ACE inhibitor therapy, in contrast to eight
patients with bilateral renal artery stenosis where TcCI fell from 46,8
7.9 to 33.9 5.8 (P = 0.01). Split renal function studies revealed that
TcCl fell in most kidneys with renal artery stenosis (18 of 22) during
ACE inhibition, including stenosed kidneys from cases with unilateral
disease (stenosed kidneys studied N = 22; TcCl — 7.3 1.9). With
unilateral renal artery stenosis, total TcC1 was unchanged, as there was
a compensatory increase in the TcC1 non-stenosed kidney (non-
stenosed kidneys studied N = 6, iTcCl + 8.5 4.1; P <0.001 df = 26).
Serum creatinine returned rapidly to pretreatment levels following ACE
inhibitor withdrawal in all cases of acute renal failure, and TcC1 also
returned to pretreatment levels in two cases studied following ACE
inhibitor withdrawal after 2 and 4 months of therapy. We concluded that
ACE inhibitors reduced renal function in kidneys with significant renal
artery stenosis. This was reversible following ACE inhibitor with-
drawal. The long-term consequences to kidneys that develop functional
impairment during ACE inhibitor therapy are unknown.
Autoclavrng for dialyzer re-use: An alternative to chemical disinfection.
A. Wynen, K. Phelps, T. H. Mat hew, and A. Simmons. Renal Unit, The
Queen Elizabeth Hospital, Woodville, South Australia. The develop-
ment of dialyzers able to withstand autoclaving during initial factory
sterilization suggested that such dialyzers could be autoclaved as an
alternative means of disinfection in the process of dialyzer re-use. At
the completion of dialysis, the dialyzers are rinsed with reverse osmosis
water until a clear hemastix is obtained, and the dialyzers are then
capped and bagged individually. Autoclaving is done in batches and a
record and quality control program for each batch is maintained. The
efficacy of the autoclaving process (115°C for 40 mm) in clearing
dialyzers contaminated with known quantities of bacteria and fungi was
established. In vitro and in vivo clearances were performed on new and
autoclaved dialyzers.
UFR
N
Creatinine
clearance
Urea
clearance 100 200
In vitro 4 122 3 150 4
Autoclaved 6 126 5 153 8
In vivo
First use 8 118 6 154 7 232 519
Second use 13 124 6 157 4 280 602
Third use 10 124 6 158 5 258 601
Sterility testing using standard culture techniques, 14-day membrane
filtration, and pyrogen testing, along with pressure testing, was per-
formed on randomly selected autoclaved dialyzers. In no dialyzer was
any pathogen grown or pyrogen detected, and pressure testing was not
affected by the autoclaving process. Careful clinical monitoring of all
dialyses with autoclaved dialyzers (N = 400) has not revealed any
adverse reaction. Autoclaving continues to be tested in our Unit as an
alternative to formalin. Preliminary experience is that the process is
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safe and effective, well accepted by staff, less costly than formalin
re-use, and allows for appropriate quality control.
Analysis of continuous ambulatory peritoneal dialysate by SDS-poly-
acrylamide gel electrophoresis (SDS-PAGE), isoelectric focusing (IEF),
certain specific protein assays, and immune complex measurement. 1'. J.
Neale, B. Drake, and J. Muir. Department of Medicine, Wellington
Clinical School, Wellington Hospital, New Zealand. Patients with
end-stage renal disease (ESRD) managed by continuous ambulatory
peritoneal dialysis (CAPD) are subject to substantial but variable daily
peritoneal protein losses. The nature of the proteins transported into the
peritoneal fluid has not been extensively studied, but no specific
deficiency state has yet been described. One potential hazard the
peritoneum faces is vascular injury subsequent to circulating immune
complex (CIC) deposition, leading to further protein loss and possible
changes in solute flux. CAPD dialysate samples from 20 unselected,
clinically stable, uninfected ESRD patients were concentrated fIftyfold
and 300 g protein in 20 sl applied to 0.1% SDS-8% polyacrylamide gels
and to 6% polyacrylamide focusing gels within a broad ampholine
gradient (pH 3.5 to 10), providing dual resolution of protein bands.
Albumin (MWt65—69 kd) predominated on SDS-PAGE and the majority
of serum proteins (except for those of highest MW were represented in
the dialysates). IEF distinguished three major groups of proteins
according to p1, again with albumin predominating (p1 4.7 to 5.0).
Electronegative proteins (high p1) were not excluded, and no major
predominance of cationic species was evident. Material reactive in
immune complex assays was seldom detectable using polyethylene
glycol precipitation and in minute but variable quantities only in solid
phase ELISA Clq and anti C3 assays. Concentrated dialysate and
appropriate serum samples were analyzed for total protein and albumin;
P'FH, T4, TSH, FSH, LH, prolactin (7—35 kd); a1 anti-trypsin, trans-
ferrin, haptoglobins (45 to 90 kd); IgG (150 to 153 kd), IgA (160 kd), C3
(185 kd), C4 (209 to 230 kd), and 1gM (900 kd). All, with the exception
of 1gM, were commonly measurable in dialysate. Ratios of dialysate to
serum values and clearances for these proteins of diverse type varied
widely between patients. We conclude that proteins appear in CAPD
dialysate principally on the basis of size and that the largest serum
proteins are excluded. CIC, even when present in elevated amounts in
the serum, are not prominent dialysate components.
Cellular basis of host resistance in experimental pyelonephritis. T.
Miller, G. Findon, and S. Cawley. Department of Medicine, University
of Auckland, Auckland, New Zealand. Research into the biology of
pyelonephritis has been dominated by studies characterizing immuno-
logical aspects of the disease and it is clear that the host responds to
renal infection with a vigorous and protracted immune (lymphocytic)
response; the biological significance of the response and its contribution
to host defenses are still largely unresolved. We have assessed the role
of cellular components of the host defense system by determining the
effect of selective and non-selective cytodepletion on the course of
acute and chronic E. coli pyelonephritis. Particular attention has been
pald to quantitative aspects of the association between cellular and
immune competence and the outcome of infection. Cytoreduction by
total body irradiation did not affect the course of infection in the first 16
hr after challenge, even though functional neutrophil activity was
reduced to 4% of normal. Bacterial numbers had increased in the
irradiated host by 24 hr, but reached a plateau despite the greatly
reduced neutrophil response. Administration of anti-neutrophil serum
to irradiated animals further depleted the host of functional neutrophils
and resulted in a further fifteenfold increase in the level of infection.
Cyclophosphamide treatment, which ablated circulating neutrophils,
had no effect on renal infection in the early stages, but bacterial
numbers were 1,000 times greater than normal 96 hr after challenge.
Methylprednisolone administration gave similar results. Neither block-
age of macrophage and RES activity nor the absence of T lymphocytes
affected the course of infection. High levels of specific antibody at the
time of challenge was not protective. A similar pattern of results was
found when animals with chronic renal infection were subjected to the
same manipulations. The experiments have shown that the inflamma-
tory rather than the immune response is the active host defense
component in pyelonephritis. The results have refocused attention on
the role of neutrophils in host defenses mechanisms in renal infection
and helped to define the cellular basis of host resistance.
Interaction between vasopressin (AVP) and angiotensin II (A II) in
adaptation to sodium depletion in the conscious rat. B. McGrath, B.
foyer, M. Dupont, and A. Mimran. Department of Medicine, Prince
Henry's Hospital, Melbourne, Australia, and INSERM U 227,
Montpellier, France. The aim of this study was to examine the
contribution of AVP to cardiovascular hemostasis in sodium depletion
before and after inhibition of angiotensin II. Twenty-eight male
Sprague-Dawley rats were studied after 6 days of a low-sodium diet
(urinary Na 0.06 0.01 mmoles/day). Animals were randomly assigned
to four groups: control; AVPA-d(CH2)5 Tyr(Me)AVP; MK 422, and
AVPA plus MK 422. Left ventricular and left femoral arterial catheters
were inserted under light ether anesthesia. After 90 mm, 5% dextrose or
MK 422 (1.5 jtg/niin) was infused via the left ventricular catheter (0.018
mI/mm), followed 20 mm later by a bolus of AVPA (10 gIkg) or
vehicle, and 10 mm later cardiac output and distribution of blood flow
were determined (microsphere technique). Blood pressure and heart
rate were monitored continuously. Pressor responses to 20 mU AVP
and 200 ng Al were examined and blood drawn for plasma ACE levels
at the end of each experiment. The inhibitors were effective as shown
by the complete inhibition of pressor responses to AVP (AVPA groups)
and Al (MK 422 groups) and suppression of plasma ACE (control vs.
MK 422: 33 4 vs. 0.4 0.3 nM/min/ml). In the control group, mean
blood pressure and heart rate were unchanged throughout the study.
The group given AVPA exhibited significant (P < 0.05) increases in
heart rate (44 15 beats/mm) and mean blood pressure (4 1 mm Hg),
but cardiac output was similar to the control group (355 39 vs. 387
27 ml/min/kg) and no changes were observed in regional distribution of
blood flow. Blood pressure fell significantly (P < 0.01) and similarly in
animals given MK 422 alone or MK 422 plus AVPA (12 1, 14 3 mm
Hg) due in each case to fall in total peripheral resistance. Renal blood
flow increased significantly with MK 422 compared to controls (9.7
0.7 vs. 7.4 0.2 ml/min/g, P < 0.02) and increased further in the
presence of AVPA (12.3 0.8, P < 0.05 vs. MK 422). A similar trend
was observed for mesenteric blood flow; other organs were unchanged.
AVP may play a contributing role in the adaptation to sodium depletion,
particularly via an effect on the renal vascular bed, but the latter is only
revealed after removal of the dominant influence of All.
End-stage renal failure due to HLA-llnked familial hypokalemic inter-
stitial nephritis. M. Wallace, D. Bruton, A. North, and D. Wild. Renal
Unit and Pathology Department, Waikato Hospital, Hamilton;
Auckland Regional Blood Transfusion Service; Meat Industry Research
Institute of New Zealand, Hamilton, New Zealand. Three of seven
siblings presented in end-stage renal failure, with hypokalemia, normal
blood pressure, and identical tissue types (A3, 32; B5, 7; DR4, 6). None
of the other siblings have any evidence of renal disease, nor do the
parents. None of the unaffected siblings nor the parents share both
HLA haplotypes with the affected siblings. Renal biopsy changes in one
affected sibling were those of hypokalemic nephropathy only. Linkage
analysis, assuming recessive mode of inheritance, gave a maximum
LOD score of 1.70, with odds of 50.57 to 1 in favor of linkage between
the renal defect and HLA system inheritance (P < 0.02). This family
pedigree combined with that of a similar family described by Gullner et
al (Trans Assos Am Phys, 92:175—88, 1979) makes it likely that genetic
information to do with potassium metabolism is carried on the short arm
of chromosome six (combined probabilities that it is a chance associa-
tion: P < 0.001).
The transepithelial and transmembrane potential difference and resist-
ance of the papillary collecting duct of the rat. T. 0. Morgan and D.
Haberle. Department of Physiology, University of Melbourne,
Melbourne, Australia, and Physiology Institute, University of
Munchen, Munchen, Federal Republic of Germany. The role of the
papillary collecting duct is ill defined and has been difficult to study.
However, it is located in such a position that it may be the final modifier
of urine composition. Papillae were isolated from Sprague-Dawley rats
and incubated in a tissue bath at 37°C. Collecting ducts were punctured
and microperfused. Current was injected through the perfusion pipette
and the signal recorded in the bath and also downstream from the
perfusion pipette with a microelectrode. Subsequent recordings were
made closer to the perfusion site. The diameter and distance of the
collecting duct were measured and the specific resistance and cable
resistance was calculated. There was no significantly negative transepi-
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thelial PD. The resistance of the epithelium was high and the length
constant was 1.5 0.4 mm. The epitheial cells of the collecting duct
were punctured with microelectrode. The PD of these cells was usually
greater than — 80 mV and on occasions was as high as — 120 mV. The
transmembrane PD was destroyed by adding K to the medium, and,
when K was removed, the cells on some occasions hyperrepolarize.
These results indicate that, in vitro with identical solutions on both
sides of the epitheium, there is no large negative transepithelial
potential difference across the papillary collecting duct. The cells,
however, have a large negative PD. This infers that any sodium
reabsorption in the collecting duct takes place by an electro neutral
process and casts doubt on the usually accepted mechanism of sodium
reabsorption in this segment.
The effect of afrial natriuretic factor (AN!?) on renal fimetion in the rat. J.
Stevens and T. Morgan. Department ofPhysiology, University of Melbourne,
Parkvile, Australia. Atrial natriuretic factor causes a natriuresis and vascular
dilatation. It is unclear if these are independent effects. The present study
determined the dose response in different stages of hydration. Sprague-
Dawley rats were prepared so they had equal urine flow rates (100 id/min) due
to a saline or a water diuresis. The effect of 100,200,500, and 1,000 ng bolus
of synthetic AI.F (gift of M.S.D.) on blood pressure and renal function was
measured. Alterations in blood pressure were similar in both groups of rats
and only occurred with 1,000 ng. Rats in water diuresis achieved a natriuresis
with a lower concentration of ANF. In water-loaded animals, in the 5-mm
penod after ANF, urine sodium concentration increased from 11.7 2.3 to
43.8 4.0mmoles/liter, but there was no increase in the rats in saline diuresis.
Changes in urine flow rate only occurred with the higher dosages, and, with
1,000 ng, flow rate trebled. Potassium excretion did not alter with the low
dose, but increased with 1,000 rig. The responses indicated that natriuresis
occurs with a dose of ANF that has no measurable effect on blood pressure
and that the natriuretic response takes place at a lower concentration in rats
in water diuresis. The pattern of increased sodium excretion in rats in water
diuresis suggests that the effect is exerted on the medullary or papifiary
collecting duct. The effect could be an inhibition of sodium reabsorption or
possibly an increase in sodium penneability, allowing sodium to enter the
collecting duct from the papillary interstitium and thereby causing a nattiure-
sis. The vascular effect appeared to be similar in each group. The data
suggests that an effect on tubule transport of sodium is the prime effect and
that vascular effects only occur with high concentrations.
Sequential changes In acute renal failure from nephrotoxic tubular
necrosis. S. L. Skinner, M. A. Henry, P. J. Harris, R. J. Naughton,
andJ. D. Tange. Departments of Physiology and Pathology, University
of Melbourne, Melbourne, Australia. Severe reproducible renal tubular
necrosis can be induced in rats by a single i.v. dose of p-aminophenol.
In this experimental model, it has been shown (Davis et a!, Kidney mt
24:740—747, 1983) that the earliest functional changes, 40 to 90 mm after
injection of nephrotoxin, are parallel rapid rises in proximal and distal
tubule pressures, increased fractional excretion of sodium and water,
with falling glomerular filtration but with little change in urine flow rate
or renal blood flow. Light and electron microscope studies showed that
these events are accompanied by changes in proximal convoluted
tubule cells short of necrosis and occur in the absence of cast formation.
It has been postulated that a functional block occurs beyond the distal
tubule at the connecting tubule in the outer medulla. The present study
reports the progression of these changes beyond 90 mm and up to 4 hr.
Intratubular pressure returned towards normal over this period, anuria
developed and proximal convoluted tubule epithelium became necrotic
and casts, protein and cellular debris appeared in tubule lumens. Renal
blood flow was maintained throughout. Falling tubular pressures and
anuria correlaed with necrosis, indicating that tubular epithelium loses
its integrity later than previously recognized. In this model, acute renal
failure occurs at normal urine flow and without cast formation. Cast
formation appears to be an associated phenomenon rather than a causal
factor in acute renal failure.
Renal hemodynamic and hormonal responses to acute protein feeding
in normal humans. C. P. Swainson and R. Walker. Christchurch
Clinical School of Medicine, Christchurch, New Zealand. Increases in
renal blood flow (RBF) and glomerular ifitration rate (GFR) occur in
normal humans following protein feeding, but the mechanisms are
unknown. Five normal men starved for 36 hr, then ate a 150 g protein
meal of cheese, eggs, and casein. Hemodynamic and hormonal mea-
surements were made before and at 2 and 4 hr after eating. RBF and
GFR were estimated from three PAH and creatinine clearances during
moderate water diuresis in each period. Norepinephrine (NE) and
epinephrine were measured radioenzymatically, and plasma renin ac-
tivity (PRA), aldosterone, antidiuretic hormone (AVP), and urinary
Tamm-Horsfall protein (THP) by radioimmunoassays. Mean RBF and
GFR rose 20 and 27%, respectively, at 2 and 4 hr. TcH2O fell 30%.
Afferent arteriole resistance fell by 20% at 4 hr, but efferent resistance
fell at 2 hr and rose to control values by 4 hr. PRA, PGE2, and NE all
rose significantly, but PRA and NE returned to control values by 4 hr;
THP rose 20%. Renal vasodilatation after protein feeding occurs
despite marked activation of the adrenergic sympathetic nervous sys-
tem, and may be mediated by an increase in PGE2. This mechanism
seems to be a reversal of normal tubuloglomerular feedback.
